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ABSTRACT 
 Ergosterol is the major sterol found in the membranes of Chlamydomonas 
reinhardtii.  While past studies have identified some ergosterol mutants in C. reinhardtii, 
very little is known about sterol biosynthesis pathways in this species.  With the 
elucidation of the Chlamydomonas genome, bioinformatics analysis has allowed us to 
determine potential genes involved in ergosterol biosynthesis.  With this knowledge, a 
working model of the pathway was designed for future analysis. Several of the ergosterol 
biosynthetic genes were analyzed in respect to their role and involvement in flagellar 
regeneration. These genes were upregulated during the regrowth of the flagella.  Also 
Chlamydomonas strains lacking flagella were analyzed by Q-RT PCR to determine what 
role ergosterol biosynthetic genes played in the absence of their flagella.  Finally, one of 
the genes with homology to the yeast sterol C-5 desaturase, ERG3, was chosen for further 
analysis.  To test whether ERG3 of C. reinhardtii had a similar function, yeast 
Saccharomyces cerevisiae ERG3 knockout strains were created to assess whether a 
plasmid expressing the Chlamydomonas ERG3 could complement the deletion. These 
erg3 null mutants were transformed with a vector expressing ERG3 cDNA from C. 
reinhardtii driven by the yeast ADH1 promoter, and this expression was able to restore 
ergosterol biosynthesis and reverse phenotypes associated with lack of ERG3 function. 
Complementation of these erg3 null phenotypes strongly suggests that ERG3 in C. 
reinhardtii functions as a sterol C-5 desaturase.  Results from this dissertation provides 





REVIEW OF LITERATURE 
 
 
1.1  Overview of Sterol Lipids  
 
 Sterols are lipid-soluble molecules containing a four-ring structure with a 3β-
hydroxyl group and an aliphatic side chain of 8 or more carbon atoms.  Sterols fall under 
the macromolecule class of lipids.  They are resistant to saponification, and are found in 
abundant quantities in all animal and plant tissues. The physiology and viability of 
eukaryotic cells depends on the presence or absence of sterols.  Therefore, there is great 
variation between the classes of sterols in specific cell types as well as species.  The 
major differences in sterols include the number, location and orientation of double bonds 
and side chains (Fahy et al., 2005).  The nomenclature of sterols is basically defined and 
based upon the “tetracyclic skeleton” as seen in Figure 1.1 (Moore, 1993).  The 
tetracyclic skeleton is composed of carbons 1-27 while carbons 28, 29, 30, 31, and 32, are 
subsequently added to the molecule (Fahy et al., 2005).  In the sterol nucleus, the up 
conformation is referred to as β while the down conformation is α.  The conformational 
orientation of the side chain is the exact opposite, as the up conformation is denoted as α, 
while the down conformation is described as β (Fahy et al., 2005).  For example, the 
major differences associated with algal, plant and fungal sterol lipids have a great deal to 
do with variations in the side chains (Moore, 1993).  Lanosterol, an ergosterol precursor 
in yeast produces sterols in the S configuration, while in plants, cycloartenol is the 
precursor, and its sterol products are found in the R configuration (Moore, 1993).  
Understanding this complex nomenclature system is integral for proper identification of 






Figure 1.1  Sterol nomenclature.  Each ring is denoted as either A, B, C, or D. ∆ with a 
superscript number denotes the location of a double bond from that carbon to the carbon 
with the next higher number.  Double bonds between carbons can also be indicated by the 
carbon with the lower number followed by the carbon with the higher number, the latter 
in parentheses. The position of a carbon in the molecule is indicated by C- followed by a 
number.  C with a subscript number explains the total number of carbons in the molecule. 







While naming sterol lipids and understanding their phylogenetic differences have 
been very important aspects of lipid biochemistry, the function of lipids and sterols has 
been an even more intriguing field of study.  Lipids are a major component of cell 
membranes.  Membranes are dynamically changing entities that possess not only lipids 
but proteins as well.  The Singer-Nicholson fluid mosaic membrane model proposed that 
there are random components of the membrane that allow for indiscriminate rotational 
freedom of molecules (Singer, 1972, Singer & Nicolson, 1972).  After years of research, 
scientists have been able to refine this model.  It is now thought that this random 
movement of molecules is in actuality very unambiguous. Scientists argue that there 
needs to be a paradigm shift from the previous Singer-Nicholson model to a more 
updated model incorporating membrane microdomains.  There are six characteristics of 
cell membranes that do not fit with the Singer-Nicholson model: (i) specific patterns of 
distribution for receptors in the plasma membrane, (ii)  lipid associations with signaling 
molecules, (iii) unrestricted diffusion of particles through a shorter diffusion barrier, (iv) 
lipids associate with specific membrane proteins, (v) presence of integral proteins 
maintain membrane domains, (vi) protein reorganization to allow for protein-protein and 
lipid-protein interactions (Vereb et al., 2003). These physical characteristics of the 
membrane enhance the previous model of a more random unorganized, description of 
lipids and proteins as described by Singer and Nicholson.  The movement of lipids and 
proteins in the membrane are far from unrestricted. 
Membranes are essential components of eukaryotic cell function.  The plasma 
membrane is particularly significant since it separates the inner compartments of the cell 
from the outside environment.  Sterols are important lipid components of the plasma 
membrane, and have been shown to play crucial roles in several cellular functions.  
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Detailed studies of sterols have focused primarily on understanding how sterols influence 
membrane fluidity and permeability.  The effects of sterols on the activity of membrane 
bound enzymes and rates of cell growth have also been of significant interest.                
1.2  Physiological Role of Sterols                                                                                       
 As vital components of the plasma membrane, sterols play a critical role in 
maintaining the structure and viability of the cell.  The primary biophysical role of sterols 
is to maintain the spacing between phospholipid molecules of the membrane bilayer in 
order to restrict van der Waals forces (Figure 1.2).  Homeostasis is best maintained in the 
cell when the membrane is functioning at an optimal fluidity.  At high temperatures, 
lipids can weaken and become too fluid-like, while at lower temperatures, the lipid 
bilayer can become too rigid and solidify.  The presence of sterols prevents solidification 
at lower temperatures and melting or weakening of the membrane at higher temperatures.  
While this is not the only physiological role of sterols, this phenomenon has been quite 
intriguing to the scientific community.  Maintenance of the membrane fluidity continues 
to be a well-defined role of sterols (Solomon et al., 2008).                                              
 One prominent sterol found in the membranes of many fungal species is 
ergosterol, which is the primary sterol lipid in Sacchromyces cerevisiae (Daum et al., 
1998).  The post-squalene biosynthesis of ergosterol in yeast has been well defined 
(Arthington-Skaggs et al., 1996, Osumi et al., 1978).  Enzymes of the ergosterol 
biosynthetic pathway have been found to be major targets for drug interactions (Balliano 
et al., 1989, Rao & Grollman, 1967, Siegel & Sisler, 1965, Cohen & Eaton, 1979), as 
many modern antifungal drugs on the market were derived specifically to target 
ergosterol biosynthesis (Cowen & Steinbach, 2008, White et al., 1998). For example, 





Figure 1.2  Schematic Diagram of the Phospholipid Bilayer. (A) Phospholipid bilayer 
with an integral membrane protein. (B) Phospholipid bilayer with an integral membrane 
protein embedded with sterol molecules to increase the spacing and maintain fluidity of 
the bilayer. This figure was adapted from the original Singer-Nicholson model (Singer, 








responsible for converting lanosterol to 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol 
(Aoyama et al., 1981, Parks et al., 1995, Kalb et al., 1987, Barrett-Bee & Dixon, 1995).                                                                                                                            
 Overall, ergosterol plays a very important role in other lipid biosynthetic 
pathways.  Several processes in phospholipid biosynthesis are regulated by ergosterol. 
Phospholipid composition is affected by the transfer rate of phospholipids by 
phosphotidylinositol-transfer protein when stimulated by ergosterol (Szolderits et al., 
1989).  Ergosterol is known to upregulate the activity of phosphatidylinositol kinase, 
(Dahl et al., 1987, Dahl & Dahl, 1985) and the methylation of phosphatidylethanolamine 
to phosphatidylcholine is also stimulated by ergosterol (Kawasaki et al., 1985).  In 
addition, evidence exists for crosstalk between ergosterol and other lipid metabolic 
pathways.  Ceramide production is down-regulated when 3-hydroxy-3-methylgutaryl-
CoA reductase, a critical enzyme in ergosterol biosynthesis, is inhibited by lovastatin in 
mammalian cells (Storey et al., 1998).  Microarray analysis has shown that expression of 
genes involved in long chain fatty acid synthesis is significantly affected when ergosterol 
biosynthesis is blocked (Bammert & Fostel, 2000).                                                   
 Specific lipids are responsible for increasing the order and organization of 
membrane domains.  These unique proteins and lipids organize to form lipid rafts.  In 
vertebrates, three specific lipids act as major precursors to the lipid raft: sphingolipids, 
phospholipids and cholesterol, the structures of which are depicted in Figure 1.3.  Lipid 
rafts have roles in cell signaling, protein synthesis, cell cycle regulation, and 
phosphorylation of different regulatory kinases (Simons & Toomre, 2000).  The outer 
leaflet of rafts is normally comprised of glycosphingolipids and sphingomyelin, while the 
inner leaflet contains glycerolipids with fatty acyl chains.  In vertebrates, cholesterol is a 




Figure 1.3  Three major molecules involved in lipid raft formation.  (A) cholesterol; 




rigid due to its four ring structure, and thereby functions to increase the fluidity of the 
membrane by thermodynamically reacting with other lipids to change the gel phase to a 
liquid ordered phase.  With cholesterol present, the membrane is inhibited from moving 
into the crystalline state.  Cholesterol buries itself between the hydrocarbon tails of the 
sphingolipds, and in its absence lipid rafts lose all integrity and may fall apart (Simons & 
Toomre, 2000).  The Golgi apparatus is thought to be the organelle in cells in which lipid 
rafts are assembled (Brown & London, 1998).  After synthesis of cholesterol and 
sphingolipids in the endoplasmic reticulum these molecules are then moved to the Golgi 
for lipid raft assembly (van Meer, 1989).  In recent years, researchers have been able to 
identify the lifetime of lipid rafts in the cell.  It was previously thought that these 
microdomains were very stable, but now information has become available indicating 
that lipid rafts are short-lived in the cell, perhaps existing for only “tens of seconds” 
(Edidin, 2001).  In general, rafts are relatively small in size in order to maintain “raft-
borne signaling proteins” in a state of inactivity (Simons & Ehehalt, 2002).  When 
activated, rafts assemble into larger platforms by which functionally related proteins can 
then interact and crosstalk (Simons & Ehehalt, 2002).  There are several diseases that are 
related to defects in assembly of lipid rafts.  Those include Alzheimer’s disease, 
Parkinson’s disease, diabetes, and osteoarthritis (Simons & Ehehalt, 2002).  Lipid rafts 
are extremely important for maintaining the viability of an organism.  It is thought that 
changing cholesterol levels in the cell can affect the “association pattern” of lipid rafts 
(Matko & Szollosi, 2002).  Cellular uptake of cholesterol can affect transcriptional 
regulation of genes involved in the pathway as well as the ability to properly cluster and 
assemble rafts (Tall et al., 2002). 
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1.3  Overview of Sterol Biosynthesis                                                                                
 Two major pathways for sterol biosynthesis have been found in eukaryotes.  
Fungi and vertebrates synthesize sterols with lanosterol as an intermediate, while plants 
synthesize sterols using cycloartenol as an intermediate.  In these pathways the 
biosynthetic steps from isopentanyl PP (IPP) to squalene epoxide are the same.  
However, the cyclization of squalene epoxide is where the two pathways diverge 
producing either cycloartenol or lanosterol. (Figure 1.4).  Less is known about the 
biosynthesis of sterols in algal species.  Red algae, green algae and diatoms are thought to 
make cycloartenol while dinoflagellates have been reported to make lanosterol (Baker & 
Kerr, 1993, Giner, 1993).                                                                                                  
 There is a some evolutionary difference between sterols found in mammals, fungi, 
higher plants, algae, and some protozoans (Bloch, 1983). There are significant structural 
differences between cholesterol and ergosterol, the central sterols of eukaryotic 
organisms (Figure 1.5).  Ergosterol has two double bonds at C-7 and C-22 and a side 
chain methyl group at C-24.  It has been suggested that cholesterol is found in 
mammalian cells because of its ability to function in the optimization of membrane lipid 
packing for the purpose of maintaining rigidity and fluidity dependent on temperature and 
cell size (Bloch, 1983, Arora et al., 2004), while ergosterol is favored in lower eukaryotic 
species to enhance membrane disorder as a substitute for the production of unsaturated 
fatty acids (Bloch, 1983).                                                                                                   
1.4  Sterols in Eukaryotic Organisms 
Sterols are found in the membranes of most eukaryotic organisms (Bloch, 1983).  
Even though there are similarities, the differences between mammalian, fungal and plant 




Figure 1.4  Schematic diagram showing the evolutionary branch from IPP to 
lanosterol and cycloartenol. 
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is cholesterol, which is an intermediate in the synthesis of Vitamin D, bile salts and 
hormones.  Plant cells contain sitosterol, while fungal cell membranes have ergosterol as 
the major sterol components (Bloch, 1983). Plants have a variety of sterols including 
sitosterol, 24-methyl cholesterol and stigmasterol (Benveniste, 2004).  Ergosterol is also 
found in the membranes of protozoan parasites, Leishmania and Trypanosoma (Mbongo 
et al., 1998), and interestingly, the eukaryotic model system, Drosophila melanogaster, 
where it is a major sterol lipid (Rietveld et al., 1999).                                                       
 While the study of sterol biosynthesis in eukaryotic organisms has looked 
primarily at the functional role of sterols in terms of end-product sterol formation, 
scientists have also examined the production of sterols not as strict precursors but also as 
hormonal regulators as well (Norton & Nes, 1991).  In mammalian cells, cholesterol 
serves as the precursor to the hormonal regulators, testosterone and estrogen.  Like 
testosterone and estrogen, brassinosteroids in higher plants act as sterol hormones to 
coordinate several cellular processes (Bajguz, 2007).  To date, no steroidal hormones 
have been identified in C. reinhardtii. However, in another algal species, Prototheca 
wickerhamii, two new steroidal triene hormones have been identified (Norton & Nes, 
1991).  Interestingly, a great deal of research has also been done to elucidate specific 
steps in ergosterol biosynthesis by which pathogenic organisms like Trypanosoma brucei 
might be eradicated.  Scientists have shown that the import of cholesterol in this model 
system does not diminish ergosterol biosynthesis or the hormonal importance of the 
molecule in T. brucei, but introducing an analog of the sterol C-24 methyltransferase 
does effectively stop the growth of the organism in the bloodstream (Zhou et al., 2007).  
This is just one example of how sterols play multiple roles in the cell across several 
different eukaryotic species, and how an understanding of their synthetic pathways may 
  13 
be exploited for therapeutic purposes.                                                                               
1.5  Isoprenoid Pathway                                                                                         
 Isoprenoid synthesis has been studied since the late 1950s and has given great 
insight into the biochemical process in photosynthetic higher plants and algae. Sterols are 
a direct end product of isoprenoid biosynthesis.  For many years there has been a debate 
about whether or not there are two distinct pathways for the synthesis of isopentenyl 
diphosphate (IPP).  It is thought that IPP serves as the common C5 precursor that aids in 
the production of most isoprenoids including sterols.  
  3 Acetyl- CoA                 Mevalonate                  IPP 
                       
 
 
                                                                OR 
 
                       Pyruvate 
 
                         1-deoxy-d-xylulose-5-phosphate               IPP 
 
                       GAP 
 
Figure 1.6 The classical formation of Δ3 –isopentenyl diphosphate (IPP) by the 
acetate/mevalonate pathway and the alternative 1-deoxy-d-xylulose-5-phosphate 
(DOXP) pathway.  Chlamydomonas reinhardtii uses the DOXP pathway to synthesize 
sterols in the cell. 
 
By radioactive incorporation experiments, it has been shown that C. reinhardtii, uses a 
mevalonate independent pathway to synthesize its sterol molecules (Lichtenthaler, 1999).  
IPP is generated by the DOXP pathway as seen in Figure 1.6 (Schwender et al., 1999).  
By labeling 1-deoxy-d-xylulose-5-phosphate, it has been discovered that incorporation of 
the molecule was found in the isoprene units of C. reinhardtii (Steele et al., 1969).     
 From an evolutionary perspective, the DOXP pathway is distributed among 
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photosynthetic algae and higher plants.  Euglena appear to have lost the DOXP pathway 
for the synthesis of IPP (Lichtenthaler, 1999, Van Den Hoek, 1997).  They rely solely on 
the mevalonic acid pathway for the production of isoprenoid products, whereas green 
algae such as C. reinhardtii have been able to utilize the DOXP pathway for sterol 
synthesis (Steele et al., 1969).  It is also maintained that in Arabidopsis and C. 
reinhardtii, DOXP synthase possesses a signal peptide sequence implying its localization 
for the pathway in the plastids (Mandel et al., 1996).  Isoprenoid synthesis has been 
known to take place in the chloroplasts (Lichtenthaler et al., 1997, Moore, 1993).  
Cyanobacteria use the DOXP pathway and are thought to be the “progenitors of the 
chloroplast,” but through the co-evolutionary process with eukaryotes, the DOXP process 
was compartmentalized in higher plants (Mandel et al., 1996, Nicolson & Singer, 1972). 
 In conclusion, the early studies in isoprenoid biosynthesis demonstrated the 
diverse nature of algal, fungal and higher plant metabolic pathways.  Chlamydomonas 
reinhardtii utilizes the DOXP pathway for the production of isoprenoids.  Future work in 
this area will be of utmost importance for characterizing the genes and enzymes that 
coordinate the synthesis of isoprenoids and precursors to sterols in the membrane of this 
model system.  
1.6  S. cerevisiae as a Model Organism for Study of Ergosterol Biosynthesis 
 
 Much like cholesterol biosynthesis, ergosterol synthesis has been widely studied. 
The yeast, Sacchromyces cerevisiae, has been used as a model system for the study of 
this membrane component. Many antifungal agents have been created to target the 
enzymes of ergosterol synthesis, thus killing the fungal organism.  The ergosterol 
pathway is catalyzed by at least eleven enzymes (Figure 1.7). These enzymes perform a 
series of biochemical steps to change the unsaturated, linear squalene structure to the four 
  15 
ring sterol, ergosterol.  The chemical name for ergosterol is 24β -methylcholesta-5,7,22-
triene- 3β-ol.  Scientists are able to grow cultures of S. cerevisiae at a relatively low cost 
and manipulate genes of the ergosterol biosynthetic pathway in order to better identify 
the function of each enzyme (Daum et al., 1998, Parks & Casey, 1995).  There is a yeast 
knockout library that is commercially available.  Ergosterol biosynthetic genes have been 
deleted and their phenotypes are well catalogued and documented 
(http://www.yeastgenome.org). As with C. reinhardtii, the entire genome of S. cerevisiae 
is sequenced and available for analysis.  The yeast genome contains a total chromosomal 
sequence of approximately 12 Mb with a haploid set of 16 chromosomes that range in 
sizes as small as 200 kb to 2,200 kb (Sherman et al., 2002).  The sequence, released in 
1996, identified 6,183 possible ORFs encoding proteins greater than 100 amino acid long 
(Sherman et al., 2002).  Functional complementation of ergosterol biosynthetic genes in 
yeast can be performed with great efficiency (Rothstein, 1983, Parks et al., 1999). In 
addition, yeast also serves as a great model system for other molecular biology 
experimental approaches such as two hybrid analysis and serial analysis of gene 
expression (SAGE) (Sherman et al., 2002).                                                                       
1.7  C. reinhardtii as a Model Organism for Study of Ergosterol Biosynthesis 
 C. reinhardtii has been well defined as a model organism for biochemical and 
molecular studies.  Historically, the organism has been manipulated for analysis of 
photosynthesis, light perception, cell cycle control, flagellar and basal body structure and 
function, as well as chloroplast biogenesis (Harris, 2001, Rochaix, 1995).  The organism 
is both unicellular and eukaryotic, and it can be grown photosynthetically, or in the  
presence of a carbon source such as acetate.  There are two mating types (mt+ and mt-) 
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Figure 1.7 The Ergosterol Pathway in S. cerevisiae. The schematic diagram shows the 


















that can be easily crossed for genetic studies.  The nuclear, chloroplast and mitochondrial 
genomes have well defined markers for efficient transformation and genetic manipulation 
(Boynton et al., 1988, Kindle, 1990, Dunahay, 1993, Shimogawara et al., 1998).  Mutant 
stocks and DNA clones are readily available for analysis 
(http://www.yale.edu/rosenbaum/ chlamy_resources.html).  EST clones and genomic 
sequences are released and updated on a one to two year basis.  There have been four 
versions of the Chlamydomonas genome released 
(http://www.biology.duke.edu/chlamy_genome/index.html, http://genome.jgi-
psf.org/Chlre4/Chlre4.home.html).  The  genome size is estimated to be approximately 
1x108 base pairs (Harris, 2001, Rochaix, 1995).  There is a codon bias that favors a high 
GC content, and upstream of these GC rich sequences there are adenosine rich elements 
(Rochaix, 1995).  On average each gene contains approximately four intron regions of 
219 bases within a kilobase of coding sequence, allowing the number of introns to be 
approximately equal to that of the coding region (Lefebvre & Silflow, 1999).  
1.8  Sterol Biosynthesis in C. reinhardtii 
Chlamydomonas reinhardtii is a unicellular alga that has great potential as a 
model system for lipid and membrane studies (Harris, 2001).  Lipids play significant 
roles in the integrity and functioning of the plasma membrane as well as organelle 
membranes.   Sterols are a major component of many membranes, including those found 
in algae.  
Flagellar membranes have been studied extensively.  In Chlamydomonas, the 
flagellar membrane seems to be somewhat different from that of the whole cell.  Prior 
research has shown that the flagellar membrane is not a continuation of the plasma 
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membrane, but is quite unique in its components (Gealt et al., 1981).  Gealt showed that 
in whole cell extracts 14:0, 16:0, 16:2, 16:3, 18:0, 18:1, 18:2 and 18:3 fatty acids, while 
flagella extracts only contained 16:0, 18:0, 18:1, 18:2 and 18:3 fatty acids.  He also 
showed that ergosterol and 7-dehydroporiferasterol were the two major sterols of the 
flagellar membranes in C. reinhardtii. The sterol composition of the membrane was 
reported to be 55% ergosterol while 45% was 7-dehydroporiferasterol (Gealt et al., 
1981).  To further study the function of sterols in this model system, Janero et al. looked 
at variations in sterol synthesis during different phases of the cell cycle (Janero et al., 
1982).  He reported high rates of sterol synthesis in mid to late G1 phase of the cell cycle 
or the light period, while it drops dramatically during the dark period.   
 In addition to lipids, proteins also are a major component of the membranes.  
Several proteins are contained in the two posterior flagella of C. reinhardtii, but one 
major protein is thought to be dominant in the flagellar membrane (Nakamura et al., 
1996, Snell, 1976).  This mastigoneme protein (Figure 1.8) extends from the outer 
membrane of the flagella into the surrounding medium.  These proteins function to 
increase swimming velocity as well as serving to anchor the cells together during the 
mating process (Witman et al., 1972).  The mechanism by which this protein reaches the 
tip of the flagella has not been elucidated.    
  Reflagellation is a naturally occurring phenomena in C. reinhardtii, allowing  the 
flagella to regenerate after excision or pH shock (Harris, 2001).  Intraflagellar transport 
(IFT) is a microtubule-dependent motility process that was first observed in the lab of 
Joel Rosenbaum at Yale University by Keith Kozminski (Kozminski et al., 1993, 
Sloboda, 2002).  This process occurs in an anterograde fashion by which soluble protein 
particles are moved from the cell body to the tip of the flagellum or cilium and back to  
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 the cell body (Rosenbaum & Witman, 2002).  IFT rafts, unlike lipid rafts, do not contain 
lipids but do occur within the cilia or flagella beneath the plasma membrane (Sloboda, 
2002, Silflow & Lefebvre, 2001). 
     
Figure 1.8 TEM pictures of isolated flagella with the intact membrane after pH 
shock. Mastigonemes are the smaller structures extending off of the sides of the flagella.  
 
But like lipid rafts they too play a role in human disease.  One of the first connections 
between IFT and human disease was established with the characterization of IFT 
complex A and B polypeptides from C. reinhardtii (Pazour et al., 2000, Pazour et al., 
1999).  Experimental evidence demonstrates that IFT particles are required for 
reflagellation as well as proper development of cilia (Pazour et al., 2000, Pazour et al., 
1999).  Defects in IFT result in polycystic kidney disease (Pazour et al., 2000, Pazour et 
al., 1999). 
1.9  Goal of This Dissertation 
  The goal of this dissertation is to elucidate sterol biosynthesis in C. reinhardtii.  
While, sterol biosynthesis in Chlamydomonas has not been studied much since the late 
Mastigonemes 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1990s, I truly hope that by characterizing the genes of the biosynthetic pathway and 
providing experimental data supporting evidence of this pathway, the scientific 
community will be excited about new pursuits in the area of lipids research.  Ergosterol 
biosynthesis overlaps with many metabolic pathways, and it is of particular interest to 
also show interactions between ergosterol biosynthesis and reflagellation.  The overall 
objectives of this work are the following: (1) to identify these biosynthetic genes for 
future studies of biodiesel alternative fuel production and (2) find the link between sterols 





                                      MATERIALS AND METHODS  
 
2.1  S. cerevisiae Strains and Growth 
  Yeast strains were constructed by homologous recombination using primers 
5’- TGC ATT TGT AAA AAA AGA TAA AA GAA AAA TAT TCG TCT AGA TTT 
GAG ATG CAG ATT GTA CTG AGA GTG C- 3’ (forward) and 5’- TCT TGA ACG 
TGA AAG AAA GAA AAA AGA TGA GAC AAA CAA GGC AAC CGT ATC TCC 
TTA CGC ATC TGT GCG G-3’ (reverse) to amplify the yeast URA3 gene flanked by 
ERG3 sequence.  Deletion of ERG3 was done in a diploid strain DDY2 (a diploid version 
of S. cerevisiae W303), which was then sporulated to produce haploid cells (see below).  
Yeast were cultured in YPD (1% yeast extract, 2% peptone, 2% dextrose) or YMD 
(synthetic minimal medium, 2% dextrose, U. S. Biologicals catalog # Y2025) 
supplemented with required amino acids and nucleotides (Sherman, 1991).   Unless 
otherwise stated, all yeast operations were carried out according to standard procedures 
(Guthrie & Fink, 1991).  To construct an ADH1 promoter vector, the plasmid pOAD used 
(Dr. Stan Fields, University of Washington) was modified as follows.   The GAL4 coding 
sequence was removed by digestion with Hind III, and re-ligated to produce the ADH1 
promoter control vector pDD1193, and ERG3 genes were cloned into the resulting unique 
Hind III site.  Expression of S. cerevisiae and C. reinhardtii ERG3 cDNA from the ADH1 
promoter of yeast expression vector pDD1193 was carried out by culture of the 
transformed yeast strain in YMD lacking leucine. 
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2.2  Yeast Competent Cell Preparation and Transformation 
 Single yeast colonies were inoculated and grown overnight.  The following the  
morning, cultures were diluted to an optical density of 0.2  (A600), and cells were grown 
until reaching an approximate optical density of 0.7.  Cells were harvested by 
centrifugation (2000xg for 5 minutes) at room temperature, and the cell pellet was 
resuspended in 1 mL of 1xTEL (10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0, 100 mM 
LiAc) per 10 mL culture volume and rocked overnight at room temperature.  Yeast were 
transformed with plasmids using the protocol of Geitz et al (Gietz & Woods, 2002). 
2.3  Yeast Genomic DNA Extraction 
Yeast genomic DNA was extracted by the Winston protocol (Hoffman & Winston, 1987). 
2.4  Tetrad Dissection 
Heterozygous diploid cells were cultured on YPD plates, then transferred to spore 
plates. A 1mm mass of cells was resuspended in 6µL Zymolase (1mg/mL) for each 
sporulation and incubated for 2 minutes at room temperature.  After incubation, 300µL of 
water was added to each sample.  Each sample solution was then spread along the upper 
portion of a petri dish and tetrads were separated with an Olympus B201 Dissecting 
scope.  Each plate was incubated at 30º C, and cells were re-patched to a master plate.  
Each master plate was then replica plated to YMD dropout plates and mating tester lawns 
to determine genotype.   
2.5  C. reinhardtii Strains and Growth 
 Dr. R. K. Togasaki of Indiana University, Bloomington provided Wild type C.  
reinhardtii 137+. Rogene Schnell, University of Arkansas-Little Rock, provided strain 
D66 (nit2-, cw15, mt+).  Strains cc477,cc478, cc479,cc480, cc482 and cc652 were ordered 
from the Chlamydomonas Culture Collection. Cultures were grown on Tris Acetate 
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Phosphate (Sueoka, 1960) (TAP) medium plates.  They were inoculated into 100 mL of 
TAP medium (Sueoka, 1960) and set to grow with continuous light (300 µE m-2S-1) and 
shaking for 2-3 days.  Aliquots of the culture were transferred to a larger flask (Sueoka, 
1960) or carboy and bubbled with high CO2 (5% CO2 in air) for several days.  Cells were 
then collected for further analysis: pH shock or RNA preparation. 
2.6  Chlamydomonas Core Library 
The Chlamydomonas cDNA core library was purchased from the 
Chlamydomonas Center (http://www.chlamy.org/).  The library was amplified using the 
host strain XL1 Blue MRF’ (Stratagene catalog number 200301) according to the 
manufacturer’s instructions at http://www.stratagene.com/lit/manuals/aspx (catalog 
number 236201). 
2.7  cDNA Cloning 
The S. cerevisiae ERG3 protein coding sequence (accession number NP_013157) 
was used to identify the C. reinhardtii EST with the best homology using the BLAST 
server (http://genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html).  Primers were 
designed based on the EST sequence in order to clone the coding region of cDNA from 
the core library described above.  The primers used to clone the cDNA by PCR included 
the forward primer 5′-GCG GCC GCC GAT CGA AGC TTA ATG TCA ACC TCG 
CTC AAA ATG A-3′and the reverse primer 5′-GCG GCC GCC GAT CGA AGC TTT 
ACT GCG CCT TGA CGG CCT T -3′.  
2.8  Bioinformatics and Sequence Analysis 
Information about genes found in Chlamydomonas was gathered from searching 
the genomic database, which yielded gene models, scaffold and chromosome locations 
(http://genome.jgi-psf.org/Chlre4/Chlre4.home.html).  Ergosterol biosynthetic enzymes 
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were obtained from Sacchromyces cerevisiae sequences on the NCBI protein database.  
The C. reinhardtii EST database using the BLAST program provided alignments with the 
yeast amino acid sequences (http://www.ncbi.nlm.nih.gov/BLAST) (Altschul et al., 
1997).  In order to determine the correct gene, E-values were considered.  The gene with 
the smallest E-value assignment was chosen as the best choice for the gene.  E-values are 
often used to differentiate between multiple copies of the same gene in the genome.  The 
E-value is a statistical value that estimates the probability of similarity between a given 
sequence and the database of sequences.  Splice sites of the exon/intron and open reading 
frames were identified by the method described by Silflow in 1995 (Silflow et al., 1995).  
ChlorP, TargetP, and SortP were used in generating data for protein prediction.  These 
programs included hyperlinks to the Expasy server (http://ca.expasy.org/tools/#translate).  
The Pfam database was used to identify possible domains in the protein sequences 
(http://pfam.sanger.ac.uk). ClustalW sequence alignment provided similarities in protein 
sequence (http://www.ebi.ac.uk/Tools/clustalw2/).  PSORT (Prediction of Protein Sorting 
Signals and Localization Sites in Amino Acid Sequences) was used to predict the 
localization of specific proteins (http://psort.nibb.ac.jp/).  The Saccharomyces genome 
database provided information about the function of the enzymes in yeast 
(http://www.yeastgenome.org/). Multiple sequence alignment programs from the 
European Bioinfomatics Institute EMBL-EBI server (http://www.ebi.ac.uk/clustalw/) 
were used for sequence analysis and alignment data.  The Prosite database from EBI 
server (http://ca.expasy.org/prosite/) was used to identify putative consensus motifs for 
specific domains.  The C. reinhardtii genomic database provided information about the 
genomic sequence, intron-exon structure, as well as information regarding potential 
membrane spanning regions of the protein coding sequence (http://genomeportal.jgi- 
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psf.org/Chlre4/Chlre4.home.html). 
2.9  Drug Resistance Screen 
Cycloheximide was purchased from Sigma Aldrich (catalog# C- 7698-1G).  S. 
cerevisiae minimal medium was prepared as previously described with the addition of 
cycloheximide (Dudley et al., 2005) at a final concentration of 0.13 µg/mL from a stock 
solution of 2mg/ml in 100% ethanol. 
2.10  Lipid Extraction 
Yeast cells were grown to an optical density at A600 of 0.7-0.8.  The cells were 
precipitated at 2000 rpm for 5 minutes and resuspended in 4mL hot isopropanol (70º C) 
for 30 minutes.  The cell wall was disrupted by vortexing with 0.5mm glass beads for 2 
minutes. Cell pellets were then resuspended in 4mL hot isopropanol and lipids were 
extracted at 70º C for 2 hours.  Next, 4mL of chloroform/methanol (1:2) and 2mL of 1 M 
KCL were added to the lipid extracts, which were vortexed and centrifuged at 5000 rpm 
on a benchtop centrifuge for 5 minutes.  The top aqueous phase was discarded and the 
previous extraction step was repeated three times.  Then, 2mL of water were then added 
to the samples. The samples were vortexed and centrifuged at 5000 rpm for 5 minutes, 
and the aqueous phase was discarded again.  Lipids were dried under nitrogen and stored 
at -80º C.  The lipid extraction protocol was derived from the Bligh and Dyer method 
(Bligh & Dyer, 1959). 
2.11  GC/MS Analysis 
Ergosterol standard was purchased from Fluka. N,O-bis(trimethylsilyl) 
trifluoroacetamide (BSTFA) was used as the silylating reagent and was purchased from 
Sigma Aldrich (catalog #33084).  100µL of BSTFA was added to dried lipid samples and 
heated to 60º C for 30 minutes.  Derivatized samples were resuspended in 25µL of 
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dichloromethane and prepared for analysis. GC/MS was carried out on an Agilent 6890 
gas chromatograph with an autosampler and Agilent 5973 mass selective detector. Then, 
1µL of sample was injected into a splitless system with a flow rate of 1mL/ min for the 
carrier gas, helium. The front inlet temperature was maintained at 250º C, while the mass 
selective detector line heater was at 280º C. The oven temperature was programmed to a 
final temperature of 300º C with an initial temperature of 100º C.  The GC column, DB-
5ms, was 30 meters by 250 µm of internal diameter with a film thickness of 0.25 µm. 
Data were acquired by selective ion monitoring to detect ions at m/z 143, 211,337, 363, 
468.   
2.12  Flagellar pH Shock 
Chlamydomonas reinhardtii wt 137 mt- cultures were grown on Tris-Acetate 
Phosphate (TAP) agar plates, and aseptically inoculated after 5 days into Tris-Acetate 
Phosphate media for 2 days with continuous shaking under light. TAP cultures were 
transferred to Minimal media (MIN) and incubated at 30ºC for 48 hours under continuous 
light and CO2 with continuous shaking. Cultures were harvested by centrifugation in a 
Beckman J2-21 centrifuge at 4ºC, 480g for 10 minutes in a JA-10 rotor. The original 
MIN medium was saved for resuspension of cells prior to flagellar regeneration analysis. 
The cell pellet was resuspended as a control in 30mL of the original MIN medium and 
incubated at 30ºC on a shaker under light.                                                                       
 Acid shock for removal of flagella: The pellet was resuspended in 50mL of 
10mM Tris-HCl buffer, pH 7.8 + 7% sucrose (w/v) at 4ºC. Cells were deflagellated by 
addition of 0.5N acetic acid to pH 4.5 and held at acid pH for 45 seconds, following 
which the pH was raised to 7.8 with 0.5N KOH (10). 15mL aliquots of the shocked cells 
were under-layered with 20mL aliquots of 10mM Tris-HCl buffer, pH 7.8 at 4ºC + 25% 
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sucrose (w/v) and centrifuged in a Beckman J2-21 centrifuge at 4°C with a JA-20 rotor 
for 11 minutes at 2000g. The 7% sucrose layer and interface was removed and flagella 
were purified by centrifugation at 27,000g.                                                                      
2.13  Total RNA Isolation                                                                                            
 Trizol reagent (Invitrogen, Carlsbad, CA) was used to extract RNA from C. 
reinhardtii.  Cells were harvested and transferred to 50 ml conical centrifuge tubes.  Cells 
were then spun at 3000 rpm for 5 minutes at a final temperature of 4°C.  The pellet was 
resuspended and transferred to 1.5 mL Eppendorf tube with one mL of Trizol. Cells were 
then vortexed and left to incubate for one hour at room temperature.  After the duration of 
the hour 200 µL of chloroform was added.  To mix the sample, the tubes were again 
vortexed and incubated at room temperature for 5 minutes.  The samples were 
centrifuged at 10,000 rpm for 15 minutes at 4°C.                                                               
 The aqueous phase of approximately 600 µL was removed and transferred into a 
fresh 1.5 mL Eppendorf tube. 0.5 mL of isopropanol was added and the samples were 
again incubated for 30 minutes.  The samples were centrifuged at 10,000 rpm for 15 min 
at 4°C. The supernatant was removed, and the RNA pellet was washed with 1.0 mL 75% 
ethanol and then centrifuged at 8,000 rpm for 5 min.  The supernatant was removed and 
the pellet was air dried for an hour. The RNA was finally treated with Ambion Turbo 
Dnase. The manufacturer’s protocol was followed and the samples were then treated by 
an RNA clean-up using Qiagen’s RNeasy Clean-up Kit.  Total RNA concentration was 
calculated by absorbance at 260 nm, using the conversion equation: 1 OD260 = 44 µg of 
RNA•mL-1.   
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2.14 Quantitative RT (Real Time) PCR                                                                       
 3µg of total RNA was used as template for synthesis of cDNA. Transcriptor First 
Strand cDNA Synthesis Kit (Roche, Indianapolis, IN) was used to synthesize the cDNA 
according to manufacturer’s instruction.  An aliquot of one-tenth synthesized cDNA was 
used as the template with Takara Bio Sybr Green Premix Ex Mix (Takara-Bio, Madison, 
WI) for quantitative PCR in an ABI Prism 7000 sequence detection system following the 
manufacturer’s instructions (Applied Biosystems, Foster City, CA).  
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CHAPTER 3 
BIOINFORMATIC ANALYSIS OF ERGOSTEROL BIOSYNTHESIS 
IN C. REINHARDTII 
 
3.1  Introduction                                                                                                                 
 In the new age of bioinformatics, scientists are faced with an interesting 
conundrum.  We now have access to sequences for countless numbers of potential genes 
without ever testing their functions in the cell.  The Basic Local Alignment Search Tool 
(BLAST) has become such an integral tool for analysis, we as scientist often forget that 
very few experiments have actually been done to elucidate and characterize these genes.  
The original papers (Altschul et al., 1997, Altschul et al., 1990) describing BLAST 
continue to be some of the most cited scientific literature articles (Geer, 2006). Many of 
the algorithms used with the original BLAST have been implemented on several genome 
websites to enhance the search for potential genes of interest (Geer, 2006).                 
 Although this vast sea of information is available with very little characterization, 
it does provide a multitude of benefits that are enhancing research.  For example, BLAST 
alignment gives greater identification of possible relationships between different species 
and genes, allowing for greater efficiency in the design of experiments.  Also, the cost 
effectiveness of the BLAST program allows science to move at lightning speed (Geer, 
2006).  One cannot truly grasp the efficiency of how this program has enhanced research 
until we look at the breadth of just one research topic such as ergosterol biosynthesis.  In 
1978, the first sterol mutants in C. reinhardtii were isolated by selecting for single 
colonies resistant to nystatin (Bard et al., 1978, Salimova et al., 1999).  In 1981, a 
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chromatographic analysis was done to identify the major sterols and fatty acids in C. 
reinhardtii (Gealt et al., 1981), in 1982, sterol synthesis was studied during the cell cyle 
by Janero et al., and finally in 1999, Salimova et al., identified three sterol mutants that 
were deficient in C24(28)reductase (Salimova et al., 1999, Janero et al., 1982).  This 
paper also identified a possible pathway for the synthesis of  ergosterol and 7-
dehydroporiferasterol based on enzyme function as seen in Figure 3.1 (Bard et al., 1978, 
Salimova et al., 1999).  However, this pathway does not show potential substrates and 
precursors for earlier biosynthetic steps of the ergosterol pathway (Bard et al., 1978, 
Salimova et al., 1999). Unfortunately, from that point on very little research has been 
published in this field.  During these earlier years, studying specific genes of the pathway 
was difficult because the BLAST tool was not yet available with the present day 
conveniences of reduced cost, algorithmic efficacy, and time efficiency, and as well as 
the Chlamydomonas genome was not yet sequenced.  With the Chlamydomonas genome 
now 95% sequenced (Merchant et al., 2007), the ergosterol biosynthetic pathway can be 
predicted, and experiments designed to characterize the functions of these genes.  Using 
BLAST alignment tools and bioinformatics technology, determinations of possible genes 
involved in ergosterol biosynthesis in C. reinhardtii can be made.  Elucidation of the 
ergosterol pathway in C. reinhardtii will provide more insight into the significance of this 
lipid molecule and provide the groundwork for possible manipulation of these enzymes 
for further analysis and study.                                                                                                     
3.2  Results                                                                                                                                            
 C. reinhardtii has been described as having two major sterols in its membrane, 
ergosterol and 7-dehydroporiferasterol (Gealt et al., 1981).  By making use of BLAST 
sequence alignment tools on the NCBI database, several enzymes in the yeast pathway 
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Figure 3.1  The Ergosterol Pathway in C.reinhardtii. This diagram shows the reactants, 
enzymes and precursors to ergosterol and 7-dehydroporiferasterol in C.reinhardtii as 
described in (Bard et al., 1978, Salimova et al., 1999).  Gene names have been added to 
the original pathway as well as the gene responsible for the alkylation of the second 
branch of the pathway that produces 7- dehydroporiferasterol. 
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for ergosterol biosynthesis were analyzed for sequence similarity in C. reinhardtii.  
Information about the structure and function of these enzymes was used to identify 
possible genes of interest involved in ergosterol biosynthesis in C. reinhardtii.  
 Sequences of ergosterol biosynthetic enzymes were gathered from the 
Saccharomyces Genome Database (www.yeastgenome.org). These sequences were then 
aligned against the JGI Chlamydomonas Genome Version 4.0 database 
(http://genome.jgi-psf.org/Chlre4/Chlre4.home.html) using the BLAST algorithm to 
identify sequences with similarity and identity.  For each enzyme two or three genes 
showed significant homology.  Only those sequences with the best E-value were chosen 
as potential candidates for each of the genes (Table 3.1).  An E-value is a statistical 
number denoting a high sequence similarity between a query and subject sequence.   
Some of the genes of the ergosterol biosynthetic pathway were then named and annotated 
by Dr. J.V. Moroney as part of his contribution to the Chlamydomonas JGI Annotation 
Team (Merchant et al., 2007).  In addition, we also determined the exon number, length 
of genomic and cDNA, as well as putative protein function (Table 3.2) (Merchant et al., 
2007), so as to better design a proposed pathway for ergosterol biosynthesis in C. 
reinhardtii (Figure 3.2).  Each gene is described based on previous research discoveries 
in S. cerevisiae.  Hopefully, this information will give scientists some groundwork to 
design more efficient experiments to begin characterization of these genes. 
3.2.1  ERG20 
 Using the S. cerevisiae amino acid sequence to search the Chlamydomonas 
genome database, one gene was identified with an E-value of e-102 (Table 3.1). Located 
on Chromosome 3, ERG20 was identified as a farnesyl diphosphate synthetase (Table 
3.2) based on its function yeast. The proposed reaction catalyzed by Erg20p is explained  
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Table 3.1.  Chlamydomonas Ergosterol Genes and Genome Location. 
 
*Derived from pBLAST alignment of CP1 and HYDRA1 from Arabidopsis thaliana. 




Table 3.2.  Chlamydomonas Ergosterol Gene Information and Protein Function.  
 
 
*Derived from pBLAST alignment of CP1 and HYDRA1 from Arabidopsis thaliana. 
Higher plant nomenclature denoted in parentheses. 
 
 
Chlamydomonas Ergosterol Gene  E-value         Genome Location   
ERG20 (FPPS)   e-102   Chromosome 3:  7017328-7021524
ERG9       2e-75   Chromosome 3:  3398442-3402247   
ERG1     5e-69   Chromosome 15:  2524204-2531216
ERG7 (CAS1)   e-103   Chromosome 1:  1873239-1882768
ERG6 (SMT1)   9e-63   Chromosome 12: 2020653-2024227
CP1*     2e-86   Chromosome 16: 1259701-1263345
ERG11 (CYP51G1)  5e-59   Chromosome 2:  2409617-2414200
CDI1*    6e-38   Chromosome 12:   8843417-8845452
ERG25    7e-13   Chromosome 6:  1665867-1669592
ERG26    3e-39   Chromosome 10:  3130700-3133000
ERG28      4e-08   Chromosome  13: 878655-881039       
ERG3     8e-25   Chromosome 16:  2115065-2117963
ERG5 (CYP710B1)  2e-52   Chromosome 18: 1235761-1240121





Figure 3.2. Proposed Pathway for Ergosterol Biosynthesis in C.reinhardtii. Sterol 
pathway showing the reactants and enzymes that catalyze the steps to synthesize 
ergosterol in C. reinhardtii.  Based on EST data from JGI VERSION 4.0, 
Chlamydomonas lacks similar sequences for ERG27 and ERG2 from S. cerevisiae, but it 
does show sequence homology with CPI1 and CDI1, genes involved in sterol 
biosynthesis in Arabidopisis thaliana.  This working model may change as these genes 
are characterized. 
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 in Figure 3.3.  The length of the genomic DNA and cDNA are approximately 1.7 kb and 
1.1 kb, respectively.  ERG20 has 12 exons (Figure 3. 4B) and a coding sequence of 1083 
nucleotides (Figure 3.4A) which encodes a 360 amino acid polypeptide (Figure 3.4C).  
ERG20 encoded a protein that also showed homology with the farnesyl disphosphate 
synthetase of A. thaliana (Accession No. CAA53433), as well (Figure 3.5). ERG20 has 
been characterized by functional complementation in yeast (Delourme et al., 1994).  C. 
reinhardtii Erg20p has 52% sequence identity to farnesyl diphosphate synthetase from A. 
thaliana and 49% identity to Erg20p in S. cerevisiae. The Arabidopsis gene for this 
important enzyme in isoprenoid and sterol biosynthesis, ERG20, is found on 
Chromosome 3 in C. reinhardtii and has 12 exons.  The gene model is completely 
supported by EST data.  The predicted 360 amino acid protein is soluble and lacks 
transmembrane helices. 
In yeast, the ERG20 homolog, is described as an essential gene that feeds C10 
precursors to several lipid pathways including sterol biosynthesis (Anderson et al., 1989).  
The enzyme functions to couple IPP to dimethylallyl diphosphate and geranylphosphate 
to produce C15 metabolites that can enter the sterol biosynthetic pathway (Anderson et 
al., 1989). Two yeast ERG20 mutants were identified and as a result produce geraniol 
and farnesol which are toxic alcohols (Chambon et al., 1990).  
3.2.2  ERG9 
Erg9p in C. reinhardtii is described as a farnesyl-diphosphate farnesyl transferase.  
The primary function of the protein is to join two farnesyl pyrophosphates to form 
squalene (Figure 3.3). This biosynthetic branch point is thought to regulate the flow of 





Figure 3.3. Schematic diagram of the elongation of squalene. Isoprene units are joined 







Figure 3.4. Full Length cDNA Sequence and Gene Structure of ERG20 and Amino 
Acid Sequence of Erg20p.  A: Full length cDNA sequence of the C. reinhardtii ERG20 
gene.  Start and Stop codons are shown in the green boxes, respectively. B: Gene 
structure of the C. reinhardtii ERG20 gene.  Start and Stop codons are denoted by the  














Figure 3.5. Multiple Alignment of ERG20.  Multiple sequence alignment of C. 
reinhardtii Erg20 protein with homologs from A. thaliana and S. cerevisiae.  The 
“*”denotes identical amino acid residues. The “:” denotes conserved residues.  The “.” 
denotes residues that are semi-conserved.
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PEST consensus motif that is thought to be a potential site for phosphorylation of 
serine/threonine residues for the purpose of ubiquitination (Rogers et al., 1986).  Erg9p 
lacks the PEST consensus motif in C. rienhardtii, but it does show sequence similarity 
with another portion of the yeast Erg9 protein.  This particular sequence, 
MMGLFLQKTNIIRDYNEDLVDGRS, is a putative prenyl substrate motif (Jennings et 
al., 1991) (Figure 3.6).  ERG9 is predicted to encode a soluble 378 amino acid protein 
and the gene structure, located on Chromosome 3, and has 10 exons and 9 introns.  
While, the genome produces a strong match for this gene with an E-value of 2e-75, the 
EST data in support of this gene model are very weak. 
 
 
Figure 3.6. Full Amino Acid Sequence of Erg9p.  The amino acid sequence of Erg9 
protein. The putative prenyl substrate motif is highlighted in the red box. 
 
3.2.3  ERG1 
 ERG1 is highly conserved among eukaryotic organisms producing sterols.  In 
Saccharomyces cerevisiae, Erg1p is classified as a squalene epoxidase and is responsible 
for catalyzing a major reaction in the ergosterol biosynthetic pathway (Jandrositz et al., 
1991). The essential role of Erg1p is to facilitate the reaction responsible for introducing 
a molecular oxygen at the 2,3 position of squalene to produce squalene epoxide (Ryder, 
1990) (Figure 3.7). By eliminating ERG1 in yeast, auxotrophic mutants are created.  
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Without an ergosterol supplement in the media, under anaerobic conditions these 
mutations are lethal (M'Baya et al., 1989).  ERG1 is also a target for the antifungal class 
of drugs called terbinafines (Ryder, 1991, M'Baya et al., 1989). 
 Like yeast and Arabidopsis, Chlamydomonas reinhardtii possesses a similar 
protein called Erg1p.  It is also characterized in the JGI Chlamy Version 4.0 Database as 
having oxidoreductase activity.  The protein is predicted to have two transmembrane 
helices.  Protein family alignment (Pfam) of the protein sequence for C. reinhardtii 
reveals a domain structure with similarities to a FAD dependent oxidoreductase.  Found 
on Chromosome 15, ERG1 has 12 exons.  Its genomic DNA is about 2.1 kilobases while 
its cDNA is 1.6 kilobases.  The gene model for ERG1 has partial EST support, there is a 
portion of the gene where there is no EST data.  It must be noted that the ERG1 gene is 
not annotated in the JGI Chlamy Version 4.0 Database. 
3.2.4  ERG7- Cycloartenol Synthase 
 Cycloartenol synthase catalyzes the reaction from 2,3 epoxysqualene to 
cycloartenol.  This critical step is a major evolutionary branch point between 
photosynthetic eukaryotes and nonphotosynthetic organisms like yeast (Benveniste, 
2004) (Figure 3.7 ).  For example, in S. cerevisiae 2,3-epoxysqualene is cyclized to 
lanosterol (Benveniste, 1986) by a 2,3- OS lanosterol cyclase or Erg7p.  Functional 
complementation of yeast mutants lacking lanosterol synthase with A. thaliana 
cycloartenol synthases led to the discovery of CAS1 (Corey et al., 1993).  Very 
interestingly, A. thaliana cycloartenol synthase has been shown to produce lanosterol 
when point mutations are present (Y410T or H477N) (Benveniste, 2004, Segura et al., 
2002, Herrera et al., 1998, Hart et al., 1999). 






Figure 3.7. Schematic diagram showing the biochemical reactions from squalene to 
cycloartenol and lanosterol.  ERG1 catalyzes the conversion of squalene to squalene 
epoxide. This step is highly conserved among eukaryotic organisms.  The branch between 
nonphotosynthetic eukaryotes and photosynthetic organisms shows the differentiation in 












35% identity between the genes.  Summons et al. has identified key amino acid 
differences between lanosterol synthase and cycloartenol synthase (Summons et al., 
2006).  Amino acids at position T/Y381, C/Q/H449, and V/I453 are conserved among 
lanosterol and cycloartenol synthase, while amino acid D455 is thought to be a highly 
conserved catalytic residue (Summons et al., 2006).  Looking at these specific amino 
acids, C. reinhardtii sequence aligns well with the higher plant sequence for cycloartenol 
synthase (Figure 3.8).  The identification of CAS1 supports the idea that C. reinhardtii 
does follow a sterol biosynthetic pathway very similar to that of higher plants.  The gene 
is found on Chromosome 1.  It has 20 exons (Figure 3.9) and sequence alignment reveals 
a 34% similarity between lanosterol synthase, Erg7p, in yeast and 58% sequence 
similarity with cycloartenol synthase in A. thaliana (Figure 3.10).  While CAS1 has been 
annotated, there is very little EST data to support this model. 
3.2.5  ERG6- Sterol-C- Methyltransferase 
 Ergosterol biosynthesis is thought to be highly conserved across several different 
species, including humans, but the biosynthetic step that ERG6 catalyzes is not found in  
Homo sapiens (Jensen-Pergakes et al., 1998).  Erg6p in yeast is a ∆(24)-sterol C-
methyltransferase (Gaber et al., 1989).  It is thought to catalyze the conversion of 
zymosterol to fecosterol by methylating position C-24 in yeast.  In higher plants, like A. 
thaliana, ERG6 is called SMT1  and catalyzes two steps.  It is responsible for both the 
conversion of cycloartenol to 24- methylene cycloartenol (Wojciechoswki et al., 1973), 
as well as catalysis of 24-methylenophonol to 24- ethylenophenol (Fonteneau et al., 
1977).  ERG6 is responsible for these two separate steps in sterol biosynthesis in higher 
plants as well as C. reinhardtii.  The primary difference between vertebrate sterols and 







Figure 3.8. Multiple Alignment of Lanosterol and Cycloartenol Synthase Across 
Species.  The colored amino acids are denoted as being diagnostic between LAS and 
CAS.  At position 381 threnonine is conserved in LAS but tyrosine is conserved in CAS. 
Likewise in position 449 is a C or Q in LAS and and H in CAS.  Poision 453 is a V in 
CAS and an I in LAS.  While posistion 455 is conserved among both as the catalytic 
amino acid  The  crystal structure of the oxidosqualene cyclase in H. sapiens has been 











Figure 3.9. Exon- Intron Structure of CAS1 in C. reinhardtii. 
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CAS1            ----MWKFISAGTTGGPLLRSLNGNKGRQTWEYDPAAGTPEQRAEAERLREEFTANKDKH 56 
CAS             ----MWKLKIAEG-GSPWLRTTNNHVGRQFWEFDPNLGTPEDLAAVEEARKSFSDNRFVQ 55 
ERG7            MTEFYSDTIGLPKTDPRLWRLRTDELGRESWEYLTPQQAAND-PPSTFTQWLLQDPKFPQ 59 
                      .       .    *  ... **: **: .   :.:: .     :  :   :  : 
 
CAS1            HHSGDELLRLQSADRIRAKKHSPPSGPVPDAPDA--ERVEEHLKGAISFYECLQQED-GH 113 
CAS             KHSADLLMRLQFS-RENLISPVLPQVKIEDTDDVTEEMVETTLKRGLDFYSTIQAHD-GH 113 
ERG7            PHP-------------ERNKHSPDFSAFDACHN------------GASFFKLLQEPDSGI 94 
                 *.             .  .       .    :            . .*:. :*  * *  
 
CAS1            FPGDYGGPMFLLPGLVITLYTCGALDQIFSPAHKKEALRYLHNHQN-EDGGFGLHIEGGS 172 
CAS             WPGDYGGPMFLLPGLIITLSITGALNTVLSEQHKQEMRRYLYNHQN-EDGGWGLHIEGPS 172 
ERG7            FPCQYKGPMFMTIGYVAVNYIAG---IEIPEHERIELIRYIVNTAHPVDGGWGLHSVDKS 151 
                :* :* ****:  * : .    *     :.  .: *  **: *  :  ***:***  . * 
 
CAS1            TMFGTGLNYVMARLLGLAAEEP--LCVKAREWMHARGGATYITSWGKFWLAVLGVYSWDG 230 
CAS             TMFGSVLNYVTLRLLGEGPNDGDGDMEKGRDWILNHGGATNITSWGKMWLSVLGAFEWSG 232 
ERG7            TVFGTVLNYVILRLLGLPKDHP--VCAKARSTLLRLGGAIGSPHWGKIWLSALNLYKWEG 209 
                *:**: ****  ****   :.      *.*. :   ***   . ***:**:.*. :.*.* 
 
CAS1            MNPLTPEMWLLPHNKWTGIGMLHPGRFWCHCRMVYLPMSYVYGKRGTCQETPLTAAIRQE 290 
CAS             NNPLPPEIWLLPY-----FLPIHPGRMWCHCRMVYLPMSYLYGKRFVGPITSTVLSLRKE 287 
ERG7            VNPAPPETWLLPYS-----LPMHPGRWWVHTRGVYIPVSYLSLVKFSCPMTPLLEELRNE 264 
                 ** .** ****:        :**** * * * **:*:**:   :     *.    :*:* 
 
CAS1            LYPMPYGRVDWNAARNQCAKEDLYYPHPLVQDILWWALYKAEN-VLQ---GSWLRRAALA 346 
CAS             LFTVPYHEVNWNEARNLCAKEDLYYPHPLVQDILWASLHKIVEPVLMRWPGANLREKAIR 347 
ERG7            IYTKPFDKINFSKNRNTVCGVDLYYPHSTTLNIAN-SLVVFYEKYLR---NRFIYSLSKK 320 
                ::. *: .:::.  **  .  ******. . :*   :*    :  *    .  :   :   
 
CAS1            ECMKHIHYEDENTRYVDIGPVNKVINMLACWLEE-PGGKAFQKHLPRVHDYLWVAEDGLK 405 
CAS             TAIEHIHYEDENTRYICIGPVNKVLNMLCCWVED-PNSEAFKLHLPRIHDFLWLAEDGMK 406 
ERG7            KVYDLIKTELQNTDSLCIAPVNQAFCALVTLIEEGVDSEAFQRLQYRFKDALFHGPQGMT 380 
                   . *: * :**  : *.***:.:  *   :*:  ..:**:    *.:* *: . :*:. 
 
CAS1            MQGYNGSQLWDTSFAVQAIAEAGLLQ--VSGHCLRKAHEYVEQSQVIEEAAAPLSAYYRH 463 
CAS             MQGYNGSQLWDTGFAIQAILATNLVE--EYGPVLEKAHSFVKNSQVLEDCPGDLNYWYRH 464 
ERG7            IMGTNGVQTWDCAFAIQYFFVAGLAERPEFYNTIVSAYKFLCHAQFDTECVPGS---YRD 437 
                : * ** * ** .**:* :  :.* :       : .*:.:: ::*.  :.       **. 
 
CAS1            ISKGAWPFSSRDHGWPISDCSSEGLKAALTLALLP-EELVGPAISPERLYDCVNVILSYQ 522 
CAS             ISKGAWPFSTADHGWPISDCTAEGLKAALLLSKVP-KAIVGEPIDAKRLYEAVNVIISLQ 523 
ERG7            KRKGAWGFSTKTQGYTVADCTAEAIKAIIMVKNSPVFSEVHHMISSERLFEGIDVLLNLQ 497 
                  **** **:  :*:.::**::*.:** : :   *    *   *..:**:: ::*::. * 
 
CAS1            NRD----GGMATYENTRSFHWLEILNPAETFGDIIVDYSYVECTSACITALCSFRKQHPG 578 
CAS             NAD----GGLATYELTRSYPWLELINPAETFGDIVIDYPYVECTSAAIQALISFRKLYPG 579 
ERG7            NIGSFEYGSFATYEKIKAPLAMETLNPAEVFGDIMVEYPYVECTDSSVLGLTYFHKYFD- 556 
                * .    *.:****  ::   :* :****.****:::*.*****.:.: .*  *:* .   
 
CAS1            HRAAEIAASLKRAEAFIRSIQRKDGSWYGSWGVCFTYACWFGATGLAALGHTYANDEALR 638 
CAS             HRKKEVDECIEKAVKFIESIQAADGSWYGSWAVCFTYGTWFGVKGLVAVGKTLKNSPHVA 639 
ERG7            YRKEEIRTRIRIAIEFIKKSQLPDGSWYGSWGICFTYAGMFALEALHTVGETYENSSTVR 616 
                :*  *:   :. *  **.. *  ********.:****.  *.  .* ::*.*  *.  :  
 
CAS1            RCAAFLADKQRADGGWGESYLSCQDKVYSHLEGD-SHVVNTAWAMLALMAVGYHKVDPEP 697 
CAS             KACEFLLSKQQPSGGWGESYLSCQDKVYSNLDGNRSHVVNTAWAMLALIGAGQAEVDRKP 699 
ERG7            KGCDFLVSKQMKDGGWGESMKSSE--LHSYVDSEKSLVVQTAWALIALLFAEYPNK--EV 672 
                : . ** .**  .******  *.:  ::* ::.: * **:****::**: .   :   :  
 
CAS1            LRRGAVFLMRMQQPSGDWPQQHISGVFNRNCMITYANYRNIFPIWALGHFRRLVLLGEEE 757 
CAS             LHRAARYLINAQMENGDFPQQEIMGVFNRNCMITYAAYRNIFPIWALGEYRCQVLLQQGE 759 
ERG7            IDRGIDLLKNRQEESGEWKFESVEGVFNHSCAIEYPSYRFLFPIKALGMYSRAYETHTL- 731 
                : *.   * . *  .*::  : : ****:.* * *. ** :*** *** :           
 
CAS1            IKINS 762 
CAS             ----- 
ERG7            ----- 
                      
Figure 3.10. Multiple Alignment of Erg7p and Cas1p.  Multiple sequence alignment of 
C. reinhardtii cycloartenol synthase protein with homologs from A. thaliana and S. 
cerevisiae. The “*”denotes identical amino acid residues. The “:” denotes conserved 
residues.  The “.” denotes residues that are semi-conserved. 
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 Erg6p or sterol- C- methyltransferase is responsible for the catalysis of this side chain. 
Preliminary information about the gene in C.reinhardtii reveals that SMT1 is 
located on Chromosome 12.  In C. reinhardtii, Smt1p is a soluble protein and is a 
member of the SAM dependent methyltransferase protein family 
(http://pfam.sanger.ac.uk).  SAM dependent methyltransferases are responsible for the 
transfer of methyl groups to other biological molecules for sterol biosynthesis and even 
DNA repair (http://pfam.sanger.ac.uk).  SMT1  in C. reinhardtii has a cDNA sequence of 
1.2 kilobases, and its intron-exon structure spans the genome at 1.8 kilobases.  
Bioinformatics evidence reveals only one copy of SMT1 in Chlamydomonas in contrast to 
the three found in Arabidopsis. There is strong EST support for this gene. The EST data 
also indicated that two forms of the Smt1 protein may exist in Chlamydomonas as there 
appears to be alternative splicing with one form of the gene.   
3.2.6  ERG25, ERG26, ERG28 – Sterol C-4 Demethylation Complex 
 The C-4 demethylation complex includes proteins Erg25p, Erg26p, and Erg27p in 
yeast (Mo et al., 2004).  The end product sterols are converted from cycloartenol by way 
of the removal of two methyl groups at position 4 and 14 (Benveniste, 2004a).  It has 
been established that three enzymes are used to convert 24-methylene cycloartenol to 
cycloeucalenol in maize embryos (Pascal et al., 1993).  The first enzyme Erg25p serves 
as a C-4 methyl oxidase (Bard et al., 1996).  Erg26p is a C4- decarboxylase/ C3- 
dehydrogenase, and finally Erg27p completes the demethylation by its 3-keto reductase 
activity (Pascal et al., 1994).  These enzymes also catalyze the conversion of 24-
methylene or 24-ethylidene lophenol to episterol and avenosterol respectively in A. 
thaliana (Benveniste, 2004a). 
 It must be noted however that A. thaliana does not show any homologous protein 
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matches for Erg27p.  Blastp search of the JGI genome database also reveals that C. 
reinhardtii also lacks an ERG27 gene.  ERG25 in Chlamydomonas is found on 
Chromosome 6 and has 6 exons. It is predicted to have 4 transmembrane domains.  
ERG26 is identified as a 2.3kb gene on Chromosome 12.  While these genes have not 
been characterized in C. reinhardtii, Smop (sterol-4α-methyl oxidase or Erg25p) from 
Arabidopsis was identified by functional complementation in yeast ERG25 mutants 
(Darnet et al., 2001).   
 From an evolutionary perspective, it is still largely unknown how or why this 
methylation is possible without the 3-keto reductase activity of Erg27p.  In 2003, Mo et 
al. showed that ERG27 was essential and required for ERG7 activity in yeast (Mo et al., 
2003).  Although Erg27p has not been identified in A. thaliana or C. reinhardtii, SMO 
genes offer new information about other possible enzymes that may be performing keto-
reductase activity in higher plants.  When SMO1 and SMO2 gene expression is reduced in 
Nicotiana benthamina, 24-methylene cycloartenol and 24-methylene and 24- ethylidene 
lophenol accumulate as precursors (Schaller, 2004).  However, there is an additional 
protein identified in yeast that is thought to stabilize and anchor the sterol C-4 
demethylation enzyme complex to the ER (Mo et al., 2004) (Figure 3.11).  This protein is 
called Erg28p and is conserved in A. thaliana as well as C. reinhardtii (Gachotte et al., 
2001).  Erg28p is found on Chromosome 13 and has 5 exons.  While this gene is not 
annotated and is poorly characterized in the JGI Genome Version 4.0, an NCBI blast of 
non-redundant protein sequences does reveal a match to the ERG28 superfamily.  
 In the current model (Mo et al., 2004), Erg28p is thought to bridge between the 
demethylation complex (Erg25p, Erg26p, Erg27p) and the other sterol biosynthetic 
proteins such as Erg3p and Erg6p (Figure 3.11A).  Another enzyme found in close 
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proximity to the Erg28p bridge is Erg2p. There were no sequences identified by a blastp 
search of yeast ERG2 to Chlamydomonas (Figure 3.11B).  Comparision of the yeast 
pathway to that of the Arabidopsis pathway reveals that this gene may not be necessary in 
order to achieve the demethylation steps and the production of the final end steps of 
ergosterol biosynthesis in C. reinhardtii (Figure 3.11C).  There was sufficient EST 
support for ERG25, ERG26 and ERG28.  However, because ERG27 was not confirmed 
after the BLASTp search, there was no EST support for this gene. 
3.2.7  CPI1- Cyclopropyl Sterol Isomerase 
 CPI1 was a very important gene to identify by bioinformatics analysis. This gene 
is found primarily in the plant kingdom and denotes use of the cycloartenol pathway 
versus the lanosterol pathway.  Cyclopropyl sterol isomerase functions to open a 
cyclopropane ring in cylcoeucalenol to catalyze the production of obtusifoliol (Rahier et 
al., 1989, Heintz & Benveniste, 1974) (Figure 3.12). This gene is primarily restricted to 
the plant kingdom. Many studies have looked at agricultural pesticide targeting to CPI1 
in higher plants (Benveniste, 1986), but this gene has not been analyzed in C. reinhardtii.  
With the exception of the bioinformatics data presented here, scientists have yet to 
investigate the role of this gene in the model system. It has been found that CPI1 is a 
drug target for two parasitic amoebae, Acanthamoeba and Naegleria (Raederstorff & 
Rohmer, 1985, Raederstorff & Rohmer, 1987).  Humans and other vertebrate organisms 
do not have this gene and therefore are unlikely to be affected by drugs specifically 
targeting CPI1.  
CPI1 is located on Chromosome 16.  The genomic DNA spans 1.9 kb and the 
cDNA is 0.8 kb in size (Figure 3.13A).  CPI1 gene has 8 exons, (Figure 3.13B), and the 





Figure 3.11. Schematic diagram of the Sterol C-4 Demethylation Complex.  (A) 
Erg28p anchors the complex in yeast and forms a bridge between Erg27p and Erg6p in 
this protein- protein interaction. Modified from (Mo et al., 2004).  (B) Erg27p and Erg2p 
are absent in the genomes of both Chlamydomonas and Arabidopsis.  (C) A proposed 






gene in C. reinhardtii, the presence of strong EST support for CPI1 does give sufficient 
data and support for the idea of a more plant-like pathway from squalene to episterol. 
3.2.8  ERG11- Lanosterol 14α-Demethylase /CYP51G1- Obtusifoliol 14α-
Demethylase                                        
 
 ERG11 and CYP51G1 are responsible for two different conversions in higher 
plants and fungi. Lanosterol is the substrate of Erg11p in yeast; in contrast, obtusifoliol is 
the substrate in higher plants (Delye et al., 1998, Taton & Rahier, 1991).  Even though 
these two enzymes utilize different substrates, they both have the conserved protein 
sequence FGxGRHxCIG that represents a Cytochrome p450 cysteine-heme iron ligand 
binding signature (Figure 3.14). While Cytochrome p450 proteins are highly substrate 
specific, heterologous complementation from yeast to higher plant is often very difficult.  
Even though a higher plant to yeast ERG11 complementation has been reported, the 
authors had to optimize the REDOX environment by overexpressing an additional 
cytochrome p450 protein in order to assist in the direct complementation of the higher 
plant ERG11 in yeast (Cabello-Hurtado et al., 1999). 
 BLASTP alignment with the yeast Erg11 protein sequence to the Chlamydomonas 
genome revealed that CYP51G1 is found on Chromosome 2 and is predicted to encode a 
sterol 14- desaturase.  With 10 exons, the gene spans 2.7 kb and its cDNA is 1.5 kb long.  
The EST support for CYP51G1 is very strong.  The sequence of Cyp51G1p is 52% 
similar to the sequence of Cyp51G1 for Arabidopsis, while, it is only 28% similar to 
Erg11p in yeast.  But, all three sequences have the Cytochrome p450 cysteine-heme iron 
ligand binding signature (Figure 3.14).                                                                            
3.2.9 ERG4/24- C-24(28) Reductase/C-14 Sterol Reductase                                     





Figure 3.12. Schematic diagram of the chemical conversion of cycloeucalenol to 




Figure 3.13. Full Length cDNA Sequence and Gene Structure of CPI1 and Amino 
Acid Sequence of Cpi1p.  A: Full length cDNA sequence of the C. reinhardtii CPI1 
gene.  Start and Stop codons are shown in the green boxes, respectively. B: Gene 
structure of the C. reinhardtii CPI1 gene.  Start and Stop codons are denoted by the  









reinhardtii is 26% similar to Erg24p in yeast, and Erg4p is found on Chromosome 7 
while ERG24 is found on Chromosome 14.  Each have their own function, but BLASTP 
search of the Chlamydomonas genome reveals only one gene for both ERG4 and ERG24.  
In C. reinhardtii, ERG4/24 is located on Chromosome 2.  The protein is predicted to have 
8 transmembrane helices, while, the gene has 7 exons and 6 introns.  C. reinhardtii 
Erg4/24p is 30% similar to yeast Erg4p and 37% similar to yeast Erg24p (Figure 3.15).  
The dual functions of Erg4/24p are sterol C-24(28) reductase and C-14 sterol reductase 
activity.  The EST support is very strong for this gene.  ERG4/24 in C. reinhardtii 
belongs to the ergosterol biosynthesis ERG4/24 family according to Pfam predictions and 
NCBI Blast predictions.  The major function of this protein is to reduce double bonds in 
the precursors of ergosterol (Lai et al., 1994).                                                                     
 While BLASTp searches with  Erg4p and Erg24p from S. cerevisiae reveals only 
one gene corresponding to both in C. reinhardtii, A. thaliana does possess a C-14 sterol 
reductase. The gene known as FACKEL (At3g52940) encodes a C-14 sterol reductase 
that catalyzes the C-14 demethylation of obtusifoliol (Benveniste, 2004b).  Fackelp has 
been characterized, and the fk mutation in A. thaliana promotes the accumulation of  Δ8,14 
sterol intermediates (Klahre et al., 1998).  A. thaliana also has a Δ24, 28 sterol reductase, 
Dwf1p.  DWF1 performs several steps in the A. thaliana sterol pathway, but its primary 
role is the isomerization and reduction of bonds located at C- 24,28 (Klahre et al., 1998).  
Unfortunately, at this time there is no purified protein of DWF1.                                      
3.2.10  CDI1- Δ8-Δ7 Sterol Isomerase                                                                     
 During sterol biosynthesis, the methyl group of Carbon 14 is removed in higher 
plants, algae and fungal species.  Following this step, Δ7 sterols are produced by a Δ8-Δ7 
isomerase (Benveniste, 2004). Erg2p is the equivalent Δ8-Δ7 isomerase, however, upon a 
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Chlamydomonas      ----MDLPPELAVLADKVLSLSPVVLVALGSAVLILALAVGRVLFNLLPSKR----PPVW 52 
Arabidopsis        ----MELDSE-----NKLLKTGLVIVATLVIAKLIFSFFTSDSKKKRLP-------PTLK 44 
Yeast              MSATKSIVGEALEYVNIGLSHFLALPLAQRISLIIIIPFIYNIVWQLLYSLRKDRPPLVF 60 
                        .:  *     :  *.   .:  :   : :*:         : *        * :  
 
Chlamydomonas      EGLPFIGGLLKFTGGPWKLLENGYAKFGECFTVPVAHRRVTFLIGPEVSPHFFKAGDDEM 112 
Arabidopsis        AWPPLVGSLIKFLKGPIIMLREEYPKLGSVFTVNLVHKKITFLIGPEVSAHFFKASESDL 104 
Yeast              YWIPWVGSAVVYGMKPYEFFEECQKKYGDIFSFVLLGRVMTVYLGPKGHEFVFNAKLADV 120 
                      * :*. : :   *  ::.:   * *. *:. :  : :*. :**:   ..*:*   :: 
 
Chlamydomonas      SQSEVYDFN-IPTFGRGVVFDVEQKVRTEQFRMFTEALTKNRLKSYVPHFNKEAEEYFAK 171 
Arabidopsis        SQQEVYQFN-VPTFGPGVVFDVDYSVRQEQFRFFTEALRVNKLKGYVDMMVTEAEDYFSK 163 
Yeast              SAEAAYAHLTTPVFGKGVIYDCPNSRLMEQKKFVKGALTKEAFKSYVPLIAEEVYKYFRD 180 
                   * . .* .   *.** **::*   .   ** ::.. **  : :*.**  :  *. .** . 
 
Chlamydomonas      WG-------ETGVVDFKDEFSKLITLTAARTLLGREVREQLFDEVADLLHGLDEGMVPLS 224 
Arabidopsis        WG-------ESGEVDIKVELERLIILTASRCLLGREVRDQLFDDVSALFHDLDNGMLPIS 216 
Yeast              SKNFRLNERTTGTIDVMVTQPEMTIFTASRSLLGKEMRAKLDTDFAYLYSDLDKGFTPIN 240 
                             :* :*.     .:  :**:* ***:*:* :*  :.: *  .**:*: *:. 
 
Chlamydomonas      VFFPYAPIPVHFKRDRCRKDLAAIFAKIIRARRESGRREE-DVLQQFIDARYQNVNGGRA 283 
Arabidopsis        VLFPYLPIPAHRRRDRAREKLSEIFAKIIGSRKRSGKTEN-DMLQCFIESKYK---DGRQ 272 
Yeast              FVFPNLPLEHYRKRDHAQKAISGTYMSLIKERRKNNDIQDRDLIDSLMKNSTYK--DGVK 298 
                   ..**  *:  : :**:.:: ::  : .:*  *:...  :: *::: ::.       .*   
 
Chlamydomonas      LTEEEITGLLIAVLFAGQHTSSITTSWTGIFMAANKEHYNKAAEEQQDIIRKFGNELSFE 343 
Arabidopsis        TTESEVTGLLIAALFAGQHTSSITSTWTGAYLMRYKEYFSAALDEQKNLIAKHGDKIDHD 332 
Yeast              MTDQEIANLLIGVLMGGQHTSAATSAWILLHLAERPDVQQELYEEQMRVLDGGKKELTYD 358 
                    *:.*::.***..*:.*****: *::*   .:    :  .   :**  ::    .:: .: 
 
Chlamydomonas      TLSEMEVLHRNITEALRMHPPLLLVMRYAKKPFSVTTSTGKSYVIPKGDVVAASPNFSHM 403 
Arabidopsis        ILSEMDVLYRCIKEALRLHPPLIMLMRASHSDFSVTARDGKTYDIPKGHIVATSPAFANR 392 
Yeast              LLQEMPLLNQTIKETLRMHHPLHSLFRKVMKDMHVPN---TSYVIPAGYHVLVSPGYTHL 415 
                    *.** :* : *.*:**:* **  ::*   . : *.    .:* ** *  * .** :::  
 
Chlamydomonas      LPQCFNNPKAYDPDRFAPPREE--------------QNKP--YAFIGFGAGRHACIGQNF 447 
Arabidopsis        LPHIFKDPDTYDPERFSPGREE--------------DKAAGAFSYIAFGGGRHGCLGEPF 438 
Yeast              RDEYFPNAHQFNIHRWNKDSASSYSVGEEVDYGFGAISKGVSSPYLPFGGGRHRCIGEHF 475 
                     . * :.. :: .*:     .               .     .:: **.*** *:*: * 
 
Chlamydomonas      AYLQIKSIWSVLLRNFEFELLD--PVPEADYESMVIGPK-PCRVRYTRRKL---- 495 
Arabidopsis        AYLQIKAIWSHLLRNFELELVS--PFPEIDWNAMVVGVKGNVMVRYKRRQLS--- 488 
Yeast              AYCQLGVLMSIFIRTLKWHYPEGKTVPPPDFTSMVTLPTGPAKIIWEKRNPEQKI 530 
                   ** *:  : * ::*.:: .  .  ..*  *: :**   .    : : :*:      
 
Figure 3.14.  Sequence similarity between ERG11 protein sequences in 
Chlamydomonas reinhardtii, Arabidopsis thaliana, and Saccharomyces cerevisiae .  
Identical protein sequences are denoted by an asterisk.  The Erg11p sequences show a 
conserved protein sequence FGxGRHxCIG that is highlighted in blue.  This motif 
represents a Cytochrome p450 cysteine-heme iron ligand binding signature. The 
“*”denotes identical amino acid residues. The “:” denotes conserved residues.  The “.” 







Blastp search of the Chlamydomonas genome, no sequences homologous to ERG2 are 
found. When taking the same ERG2 sequence and doing a Blastp search of the 
Arabidopsis genome, no equivalent matches are found.  However, another gene HYDRA1  
in A. thaliana has been identified to have a similar function to ERG2 in yeast despite its 
low sequence similarity.  HYDRA1 gene does complement the genetic phenotype of 
erg2Δ mutants in S. cerevisiae (Benveniste, 2004a, Benveniste, 2004b).  Blastp search of 
the Chlamydomonas genome with Hydra1p does reveal one gene annotated as CDI1.  
This gene has 5 exons and is located on Chromosome 12.  Although these genes are 
annotated as functioning as Δ8-Δ7 isomerases, it must be noted that there is no 
experimental evidence in C. reinhardtii to support this claim. However, the EST support 
for this gene is extremely strong.  When analyzing the sequence of Erg2p in yeast, 
Hydra1p in Arabidopsis, and Cdi1p in Chlamydomonas, there is very little sequence 
identity among the three sequences (Figure 3.16). There is a 37% similarity between 
Hydra1p and Cdi1p, while there is a 4% similarity between Cdi1p and Erg2p.                                                       
3.2.11  ERG3-C-5 Sterol Desaturase                                                                            
 ERG3 has been well characterized in yeast as a C-5 sterol desaturase (Osumi et 
al., 1979), as it catalyzes the Δ5- bond in the B-ring of ergosterol.  This enzyme is thought 
to be sensitive to cyanide and needs iron as well as molecular oxygen for its function 
(Skaggs et al., 1996).  ERG3 in yeast is also associated with NAD(P)H-cytochrome b/ 
cytochrome b5 (Osumi et al., 1979).  Deletion of ERG3 in Saccharomyces cerevisiae 
produces haploid cells that overaccumulate the ergosterol precursor episterol.                
 ERG3 in C.reinhardtii is located on Chromosome 16 of the genome and functions 
as a C-5 sterol desaturase.  The genome database predicts that this particular protein has 3 
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YeastERG24         --------------------------MVSALNPRTTEFEFGGLIGALGISIGLPVFTIIL 34 
ChlamyERG4/24      -----------------------------MGKGGTQHFEFFGPHGPAVLVLVLPAVCYAL 31 
YeastERG4          MAKDNSEKLQVQGEEKKSKQPVNFLPQGKWLKPNEIEYEFGGTTGVIGMLIGFPLLMYYM 60 
                                                  :    .:** *  *   : : :* .   : 
 
YeastERG24         NQMIRPDY---FIKGFFQNFDIVELWNGIKPLRYYLGNRELWTVYCLWYGILAVLDVILP 91 
ChlamyERG4/24      IIGCNKES---CLK-LWPEFKLPSLP---QTVSFYSN--EAMLVYLAWFFGVALLHVILP 82 
YeastERG4          WICAEFYHGKVALPKAGESWMHFIKHLYQLVLENGIPEKYDWTIFLTFWVFQIIFYYTLP 120 
                       .       :     .:           :           ::  ::    ::   ** 
 
YeastERG24         GRVMKG--VQLRDGSKLSYKINGIAMSTTLVLVLAIRWKLTDGQLPELQYLYENHVSLCI 149 
ChlamyERG4/24      GQKAEG--VVLPNGKRLTYKLN--AFRIFLITYGAALYFGFVSRQLDLGWLYDNFAQLLT 138 
YeastERG4          GIWTKGQPLSHLKGKQLPYFCN--AMWTLYVTTTLVLVLHFTN-LFRLYVIIDRFGRIMT 177 
                   *   :*  :   .*.:*.*  *  *:    :           .    *  : :..  :   
 
YeastERG24         ISILFSFFLATYCYVASFIPLIFKKNGNGKREKILALGGNSGNIIYDWFIGRELNPRLG- 208 
ChlamyERG4/24      AAIIFSSALSVYLYASSFR-----------KGALLSGHGATGYPAYDFWMGRELNPRLLG 187 
YeastERG4          CAIISGFAFSIILYLWTLFIS-------------HDYHRMTGNHLYDFFMGAPLNPRWG- 223 
                    :*: .  ::   *  ::                      :*   **:::*  ****    
 
YeastERG24         -PLDIKMFSELRPGMLLWLLINLSCLHHHYLKTGKINDALVLVNFLQGFYIFDGVLNEEG 267 
ChlamyERG4/24      GAFDLKEFCELYPGMMGWALINLGMAHKQWAATGSLTTSMLLVNVFQLYYVVDALWCEKA 247 
YeastERG4          -ILDLKMFFEVRLPWFTLYFITLGACLKQWETYGYVTPQLGVVMLAHWLYANACAKGEEL 282 
                     :*:* * *:    :   :*.*.   :::   * :.  : :* . :  *       *:  
 
YeastERG24         VLTMMDITTDGFGFMLAFGDLSLVPFTYSLQARYLSVSP---VELGWVKVVGILAIMFLG 324 
ChlamyERG4/24      ILTTMDITTDGFGFMLAFGDLAWVPFTFTSCARYLVDYP---QHLSVAATCLVLAVKLLG 304 
YeastERG4          IVPTWDMAYEKFGFMLIFWNIAGVPYTYCHCTLYLYYHDPSEYHWSTLYNVSLYVVLLCA 342 
                   ::.  *:: : ***** * ::: **:*:   : **        . .      : .: : . 
 
YeastERG24         FHIFHSANKQKSEFRQG-----------------KLENLKSIQTKRGTKLLCDGWWAKSQ 367 
ChlamyERG4/24      YAVFRGANSQKDMFRANPSD-------------PRVAHLRTLKTERGTQLIISGWWGTAR 351 
YeastERG4          YYFFDTANAQKNAFRKQMSGDKTGRKTFPFLPYQILKNPKYMVTSNGSYLLIDGWYTLAR 402 
                   : .*  ** **. **                    : : : : *..*: *: .**:  :: 
 
YeastERG24         HINYFGDWLISLSWCLATWFQ---TPLTYYYSLYFATLLLHRQQRDEHKCRLKYGENWEE 424 
ChlamyERG4/24      HINYFGDWIMGVAWCMPAGLQGLASVVPYFYCIYFASLLIHRERRDEHACRLKYGKDWDK 411 
YeastERG4          KIHYTADWTQSLVWALSCGFN---SVFPWFFPVFFLVVLIHRAFRDQAKCKRKYGKDWDE 459 
                   :*:* .**  .: *.:.  ::   : ..::: ::*  :*:**  **:  *: ***::*:: 
 
YeastERG24         YERKVPYKIIPYVY 438 
ChlamyERG4/24      YCALVRYRIVPYLY 425 
YeastERG4          YCKHCPYVFIPYVF 473 
                   *     * ::**:: 
Figure 3.15.  Sequence similarity between S. cerevisiae Erg4p and Erg24p and C. 
reinhardtii Erg4/24p. The “*”denotes identical amino acid residues. The “:” denotes 




CDI1            --MAKHPYFPLDLELPGFVPNIIPYETILTVFFGSSALVVIFMFLLTGRFKYLSSVERLW 58 
HYDRA1          MEELAHPYVPRDLNLPGYVPISMSMSSIVSIYLGSSLLVVSLVWLLFGRKK--AKLDKLL 58 
ERG2            ---MKFFPLLLLIGVVGYIMNVLFTTWLPTNYMFDPKTLNEICNSVISKHNAAEGLSTED 57 
                     .  .   : : *::   :    : : :: ..  :  :   : .: :    :.    
 
CDI1            AGWWMVTGIIHFVIEGTV--VANANFYKDTTGNILNEIWKEYAKADSRYATRDAFIVQME 116 
HYDRA1          MCWWTFTGLTHVILEGYF--VFSPEFFKDNTSAYLAEVWKEYSKGDSRYVGRDSAVVSVE 116 
ERG2            LLQDVRDALASHYGDEYINRYVKEEWVFNNAGGAMGQMIILHAS-VSEYLILFGTAVGTE 116 
                       .:     :  .    . ::  :.:.  : ::   ::.  *.*    .  *  * 
 
CDI1            GVTAFIWGPICFAIVYGILHRKAWRFTAMLLVSLGQLYGDVLYYLTCFHIGVEKHTRPEP 176 
HYDRA1          GITAVIVGPASLLAIYAIAKEKSYSYVLQLAISVCQLYGCLVYFITAILEGDNFATN--S 174 
ERG2            GHTGVHFADDYFTILHGTQIAALPYATEAEVYTPGMTHHLKKGYAKQYSMPGGSFALELA 176 
                * *..  .   :  ::.         .     :    :     : .         :   . 
 
CDI1            LYFWGYFVGANAIWIVVPVTCIIYCARHVNSAVAATG------------ 213 
HYDRA1          FYYYSYYIGANCWWVLIPSLISFRCWKKICAAAAIANNNVETKTKKKTR 223 
ERG2            QGWIPCMLPFGFLDTFSSTLDLYTLYRTVYLTARDMGKNLLQNKKF--- 222 
                  :    :  .    . .        : :  :.   . 
Figure 3.16.  Sequence similarity between Δ8-Δ7 isomerases in Chlamydomonas 
reinhardtii, Arabidopsis thaliana and Sacchromyces cerevisiae. The “*”denotes 
identical amino acid residues. The “:” denotes conserved residues.  The “.” denotes 




transmembrane helices.  The first helix is thought to be located at amino acids 10-32,  the 
second and third helix correspond to amino acids 110-132 and 191- 213.  According to 
Pfam analysis, Erg3 protein from C. reinhardtii belongs to the fatty acid hydroxylase 
superfamily.  This superfamily of proteins includes C-5 sterol desaturases as well as C-4 
sterol methyl oxidases.  ERG3 has 6 exons and 5 introns, and its protein sequence has 
similar sequence identity with Erg3p of S. cerevisiae.  The EST support for this gene is 
very strong.  This gene will be discussed further in Chapter 4.                                     
3.2.12  ERG5                                                                                                                 
 ERG5 is considered to be a member of the cytochrome P-450 superfamily in yeast 
(Kelly et al., 1997).  The primary function of this protein is the conversion of ergosta-5,7-
dienol to ergosta- 5,7,22,24-tetraen-3β-ol.  As a C-22 sterol desaturase, Erg5p catalyzes 
insertion of a double bond in the sterol side chain and is thought to be susceptible to azole 
antifungal drugs (Aoyama et al., 1984). Bard et al. identified C. reinhardtii mutants 
lacking ergosterol (Bard et al., 1978).  These mutations are consistent with a loss of 
ERG5 activity. ERG5 is found on Chromosome 18 and has 9 exons.  Pfam predictions 
designate Erg5p has having a p450 conserved domain between amino acids 214 and 413.  
JGI reveals a molecular function of monoxgenase activity.  There is partial EST support 
for this gene.                                                                                                                        
3.2.13  Ergosterol Biosynthetic Gene Expression                                                            
 In 1978, the first sterol mutants were identified in C. reinhardtii.  These mutants 
were described as being 22(23) desaturase mutants (Bard et al., 1978).  ERG5 is denoted 
as the C-22 desaturase gene in C. reinhardtii according to bioinformatics analysis.  ERG5 
catalyzes two steps in the sterol pathway of C. reinhardtii.  Erg5p helps to introduce 
double bonds in ergosta- 5,7,24(28)- trienol and stigmasta-5, 7, 24(28)- trienol to produce 
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ergosta- 5,7,22, 24(28) –tetraenol and stigmasta- 5,7,22, 24(28)- tetraenol. Upon 
investigation of one of these original sterol mutants, quantitative real time PCR (Q-RT 
PCR) revealed that cc652 does lack expression of ERG5 (Figure 3.17).  While, it is not 
known what part of the gene the point mutation exists, the Q-RT PCR results corroborate 
the original work that cc652 has a defective ERG5 gene (Bard et al., 1978).                                                   
 In 1982, Janero et al., were the first to analyze cell cycle variations in sterol 
biosynthesis in Chlamydomonas.  Their analysis revealed that sterol biosynthesis was 
highly active during the light period while there was a sharp decrease during the dark 
period.  They also demonstrated that there is a marked increase of sterol synthesis during 
the transition from the dark to the light period by some 30 fold.  With this information, it 
was decided that an analysis of specific ergosterol biosynthetic genes during membrane 
biogenesis of reflagellation was in order.  Reflagellation is the process by which the 
flagella can regenerate after manual or chemical excision such as pH shock.  Analysis of 
several key genes in sterol biosynthesis showed some sterol biosynthetic gene increases 
in expression during reflagellation (Figure 3.18).                                                                                       
 It was of interest that ERG11 showed the greatest relative expression after 30 
minutes of reflagellation.  Erg11p is responsible for the conversion of cycloeucalenol to 
obtusifoliol in higher plants (Benveniste, 2004).  The Erg11 enzyme is also extremely 
substrate specific.  ERG3, ERG4, ERG5, ERG6, and ERG7 show moderate increases in 
relative expression during reflagellation compared to ERG11.  These genes are 
responsible for some key steps in the pathway as described earlier, but it appears as 
though these genes turn on after 30 minutes of reflagellation, and then their expression 
returns to levels seen before the loss of the flagella.  However, unlike ERG3, ERG4, 




Figure 3.17 Q-RT comparative analyses between wild type cells and a well-
characterized sterol mutant cc652.  In the experiment, the expression of each sterol 
gene wild type cells was set to 1 and the expression of the mutants was compared.  The 














 cycle of 120 minutes.  When looking at the pathway, it must be noted that ERG6 is 
responsible for catalyzing several steps in the ergosterol biosynthetic pathway.  This gene 
may remain active to express more protein to catalyze these multiple steps in the 
pathway.  Finally, ERG25 and ERG26 were also analyzed to identify their levels of 
expression during reflagellation, and itappears that these genes are constitutively 
expressed.  It must be noted that these two genes are a part of the C-4 demethylation 
complex and interact in a multi-step process to remove methyl groups from carbon 4 of 
the sterol nucleus.  These observations led me to investigate whether C. reinhardtii 
“Bald” mutants that completely lacked flagella showed any changes or absences of these 
ergosterol biosynthetic genes.  The data provided no conclusive information (Figure. 
3.19)  However, cc478 gave no expression level for ERG7.  Erg7 is a critical enzyme in 
ergosterol biosynthesis in higher plants and algae as it is responsible for the conversion of 
squalene epoxide to cycloartenol versus lanosterol. It would be of specific interest to 
study whether or not this gene has any role in cooperation with other genes of the IFT 
machinery.  ERG11 is also down-regulated in strain cc478.    This data may or may not 
be significant, but cc478 does raise some interesting questions, due to the regulation of 
these two key genes, ERG7 and ERG11 during reflagellation.                                                                                                          
3.3  Discussion                                                                                                        
 Biochemical research has provided extensive knowledge about the lipid 
composition of C. reinhardtii membranes, but little is known about the enzymatic 
mechanisms by which these lipids are produced.  This chapter presents a bioinformatics 
analysis of the genes involved in ergosterol biosynthesis in C. reinhardtii.  In a recent 
review by Pierre Benveniste (Benveniste, 2004), he gives a thorough analysis and  
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Figure 3.18. Time course analysis of ergosterol gene expression during 
reflagellation.  The expression of each gene was set at 1 for the control cells. Error bars 















Figure 3.19. Q-RT analysis showing the difference in ergosterol gene expression 





















description of each gene found in Arabidopsis thaliana and the hallmark experiments 
used to analyze each specific enzyme. Comparing the material presented by Benveniste 
and the two pathways for sterol biosynthesis in S. cerevisiae and A. thaliana, we gathered 
information to construct a putative pathway in C. reinhardtii for further study and 
experimentation.                                                                                                                   
 While it has been several decades since ergosterol and 7-dehydroporiferasterol 
were identified in the cell and flagella membranes in C. reinhardtii, scientists have not 
identified any important links between these two sterols and other cellular processes in 
the cell.  However, our quantitative RT- PCR data does reveal significant ergosterol gene 
regulation during reflagellation.  Even though most of the reflagellation studies look 
primarily at intraflagellar transport proteins, there may be other aspects of this 
phenomenon of reflagellation that yet to be discovered.                                                         
 As the depth of research knowledge into lipid rafts, flagellar regeneration, 
photosynthesis and reproduction in this species continues to grow, the ergosterol pathway 
may prove to be of major interest in the manipulation of lipid species in C. reinhardtii. 
Sterol studies have proven to be extremely significant to the world of antifungal drug 
production in yeast.  Targeting the ergosterol biosynthetic pathway enzymes has offered a 
unique approach to drug design. The genes of the sterol biosynthetic pathway are often 
seen to be highly conserved across species with variations in precursors and end- 
products.  Bioinformatics analysis of the ergosterol biosynthetic pathway may allow for 
new innovative ways to identify key enzymes that may play dual roles in the structure 
and function of the cell membrane.   Identification of a proposed pathway will give the 
background information needed to now definitively study ergosterol biosynthesis in the 
model system, C. reinhardtii. 
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     CHAPTER 4 
IDENTIFICATION OF ERG3, A GENE INVOLVED IN THE 
BIOSYNTHESIS OF ERGOSTEROL IN CHLAMYDOMONAS 
REINHARDTII 
 
4.1  Introduction                                                                                                             
 One gene essential to ergosterol biosynthesis is ERG3.  ERG3 encodes the C-5 
sterol desaturase responsible for introducing a double bond at C-5 in the B ring of 
episterol (Osumi et al., 1979) (Figure 4.1). This enzyme is sensitive to cyanide and 
requires iron as well as molecular oxygen for its activity (Arthington-Skaggs et al., 
1996).  ERG3 in yeast is also associated with NAD(P)H-cytochrome b/ cytochrome b5 
(Osumi et al., 1979).  It has been previously demonstrated that ERG3 is required for the 
breakdown of respiratory substrates when cells are heme deficient (Smith & Parks, 1993).  
Deletion of ERG3 in S. cerevisiae produces haploid cells that overaccumulate the 
ergosterol precursor, episterol (Miller & Rampling, 1982, Parks et al., 1982).  Episterol 
and ergosta-7, 22-dien- 3-beta-ol are reported as possible substrates for the C-5 sterol 
desaturase (Daum et al., 1998). Cloning and sequencing of ERG3 has been reported in 
several model systems including Arabidopsis thaliana (Gachotte et al., 1996) and Homo 
sapiens (Miyazaki et al., 1999).  In yeast, ERG3 is a non-essential gene except under 
environments of heme-deficiency (Smith & Parks, 1993).  It has been suggested that Erg3 
protein is a critical target in ergosterol biosynthesis (Nes & Dhanuka, 1988), and when 
other ergosterol biosynthetic enzymes are mutated, ERG3 expression is directly affected 
and regulated by these mutations (Arthington-Skaggs et al., 1996).  Chlamydomonas 
reinhardtii, has elicited great interest as a model system in the field of lipid research, and 
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several membrane lipids of C. reinhardtii have been identified (Janero & Barrnett, 1981b, 
Janero & Barrnett, 1982a Janero & Barrnett, 1982b, , Janero & Barrnett, 1981a, Giroud et 
al., 1988). Monogalactosyldiacylglycerol (MGDG), digalactosyldiacylglycerol (DGDG), 
sulfoquinovosyldiacylglycerol (SQDG), diacylglyceryltrimethylhomoserine (DGTS), 
phosphatidylglycerol (PG), phosphatidylethanolamine (PE) and phosphatidylinositol (PI) 
are the major lipids in the membranes of Chlamydomonas, but phosphatidylcholine (PC) 
and phosphatidylserine (PS) are absent (Giroud et al., 1988).  Although, PC is absent in 
the membranes of C. reinhardtii, our laboratory has confirmed that 
ethanolaminephosphtransferase from C. reinhardtii is capable of providing for synthesis 
of both PE and PC, apparently by methylation of PE in yeast via the Kennedy pathway 
(Yang et al., 2004a, Yang et al., 2004b). Like yeast, Chlamydomonas reinhardtii has 
been reported to have two major sterols in its plasma membrane: ergosterol and 7-
dehydroporiferasterol (Gealt et al., 1981).  However, very little research has been done to 
elucidate the specific ergosterol biosynthetic pathway in C. reinhardtii, especially with 
respect to its functions and biosynthetic precursors.  In this study, we begin to 
characterize the function of ERG3 in C. reinhardtii by complementation in S. cerevisiae 
ergosterol mutants.  Understanding the substrates and respective enzymes involved in this 
very complex pathway may give greater insight into the specific role of ergosterol in this 
algal species.                                                                                                                      
4.2  Results                                                                                                                      
4.2.1  Sequence Analysis of the ERG3 Gene                                                                       
 A comparison of annotated genes in the Chlamydomonas genome to the yeast 
ERG3 revealed a few genes with significant homology. The gene with the highest 
homology had a 21% sequence identity to the ERG3 of yeast.  The gene with the next 
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highest homology had a sequence identity of only 16%, and was much more similar to 
the sequence of ERG25 in yeast than ERG3.  The Chlamydomonas gene also had a high 
similarity to ERG3 genes from higher plants. This gene was chosen for further analysis, 
and was tentatively named ERG3 (Accession No. XP_001701457).                           
 ERG3 is a C-5 sterol desaturase that adds a double bond in the ring structure of 
episterol to produce ergosta- 5,7,24 (28)-trienol in the ergosterol biosynthetic pathway 
(Broach et al., 1991) (Figure 4.1). ERG3 in C. reinhardtii is located on chromosome 16 
of the genome (Merchant et al., 2007). The predicted amino acid sequence of ERG3 
aligns well with other C-5 sterol desaturases (Table 4.1 and Figure 4.2). The ERG3 gene 
in C.reinhardtii encodes a protein of 351 amino acids (Merchant et al., 2007). The cDNA 
is approximately 1.1 kb long and has six exons according to the JGI Chlamy Version 4.0 
Genome (Merchant et al., 2007) (Figure 4.3).  Like other known Erg3 proteins, the 
homologous gene in C. reinhardtii codes for four putative histidine metal binding 
domains (Miyazaki et al., 1999) (Figure 4.2). A genome database 
(http://genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html) predicts that Erg3 protein has 
3 transmembrane helices.  The first helix is thought to be made up of amino acids 10-32,  
while the second and third helices correspond to amino acids 110-132 and 191- 213 
(Merchant et al., 2007, Marchler-Bauer et al., 2007), respectively (Figure 4.2).            
4.2.2  Deletion of ERG3 by Homologous Recombination                                            
 While ERG3 from Chlamydomonas aligned well with putative plant ERG3 genes 
(Figure 4.1), its alignment with the characterized ERG3 protein of yeast showed a lesser 
degree of identity and similarity.  To provide evidence that Chlamydomonas ERG3 
functions as a C-5 desaturase, we designed experiments to complement a yeast erg3Δ 
mutant.  To generate the null mutation in yeast, the ERG3 gene was deleted by 
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Figure 4.1 Schematic diagram of the reaction catalyzed by ERG3 in yeast.  ERG3 is 
responsible for introducing a double bond at the C-5 carbon (denoted by the asterisk) of 
the B-ring of episterol to produce ergosta- 5,7,24(28)- trienol. This step is the second to 
last step in the biosynthetic pathway to ergosterol.   
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Figure 4.2.  Amino acid sequence alignment of Sterol C-5 desaturase in different 
organisms. Arabidopsis thaliana (AtERG3) NCBI Accession Number CAA62079; Zea 
mays (ZmERG3) ACG38774; Chlamydomonas reinhardtii  (CrERG3) XP_001701457; 
Homo sapiens (HsERG3) BAA33729; Rattus norvegicus (RnERG3) NP_446094; 
Sacchromyces cerevisiae (ScERG3) NP_013157.  Conserved amino acid sequences 
shared by all organisms are denoted by an asterisk.  The highlighted area corresponds to 
the putative histidine-containing metal binding domain.  Dashed lines indicate gaps in the 
alignment. The bold, italicized font corresponds to the three putative transmembrane 
spanning regions of the Chlamydomonas ERG3 protein. 
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Figure 4.3.  Schematic diagram of sterol C-5 desaturase in C. reinhardtii as 
annotated in the JGI Chlamydomonas Genome Version 4.0.  ERG3 has six exons and 
five introns.   
 
homologous recombination and replaced with the URA3 marker in a diploid yeast strain 
(Figure 4.4A).  PCR analysis was used to identify positive yeast recombinants that 
possessed the ERG3 mutation, and these isolates were sporulated to obtain haploid erg3∆ 
strains (Figure 4.4B). Yeasts lacking a functional ERG3 are viable, as the gene is non- 
essential under aerobic conditions (Arthington et al., 1991).  In addition, yeast lacking 
ERG3 have an increased sensitivity to cycloheximide as previously described (Dudley et 
al., 2005).  Haploid isolates obtained from yeast ERG3 knockouts demonstrated increased 
sensitivity to cycloheximide when grown under optimal conditions in rich media.      
4.2.3  Complementation of ERG3 Mutants                                                                                       
 To test the function of the C. reinhardtii ERG3 gene, complementation 
experiments were conducted using yeast haploid strains deficient in ERG3.  Yeast erg3Δ 
strains display a marked hypersensitivity to low non-lethal levels of cycloheximide 
(Dudley et al., 2005). In these experiments, plasmids expressing the yeast ERG3 ORF, 




Figure 4.4.  Construction of a yeast erg3Δ  strain. (A) Schematic diagram of 
homologous recombination strategy used to delete ERG3 in Sacchromyces cerevisiae. 
PCR primers were designed to amplify the URA3 marker gene containing the flanking 
regions of ERG3. (B) Ura+ isolates were screened by PCR to verify proper integration of 
URA3 and deletion of ERG3. Only correctly integrated isolates would show a 459 base 
pair product using primers internal to URA3 and upstream of the flanking homology.  
PCR was also used to verify the downstream end of flanking region homology with 
URA3 (data not shown). 
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strains (Figure 4.5A and Table 4.2).  The selectable marker LEU2 was used to select for 
transformants on minimal media lacking leucine (Figure 4.5A), and Leu+ isolates were 
then screened for resistance to low levels of cycloheximide (Figure 4.5B).  Transformants 
containing plasmid pDD1192 expressing the yeast ERG3 ORF displayed normal 
resistance to low levels of cycloheximide (Figure 4.5B).  Transforming the mutants with 
pDD1191, expressing the Chlamydomonas ERG3 ORF, also showed enhanced resistance 
to the drug (Figure 4.5B).  Mutant strains transformed with the pDD1193, empty vector, 
displayed very little growth on plates containing cycloheximide (Figure 4.5B).  Previous 
work had also reported that yeast ERG3 mutants are viable but cannot grow on non-
fermentable carbon sources (Arthington et al., 1991, Smith & Parks, 1993, Hemmi et al., 
1995).  We used this phenotype as a second test of the ability of the Chlamydomonas 
ERG3 to complement yeast erg3Δ strains. Consistent with the earlier observations, 
transformants expressing Chlamydomonas or yeast ERG3 ORFs are able to grow on 
acetate as a sole carbon source, while the mutants transformed with the empty vector 
control cannot grow (Figure 4.5C). All strains (Table 4.3) showed positive growth on the 
control plates with minimal media minus leucine (Figure 4.5D).                                                                                   
 To further characterize the degree of complementation, qualitative GC/ MS 
analysis was performed to verify the presence of ergosterol in the complemented 
transformants.  Cultures of erg3Δ yeast expressing S. cerevisiae ERG3 or C. reinhardtii 
ERG3 were grown to similar cell densities, collected, and lipids were extracted and 
derivatized for analyses. Selected ion monitoring for ion 363 of ergosterol was used to 
search the total ion chromatograph for ergosterol in the samples (Figure 4.6).  When 
analyzing the total ion chromatograph data for specific ions of ergosterol, the knockout 
strain with the vector control was found to have a marked reduction in ergosterol in the  
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Figure 4.5. Phenotypic complementation of yeast erg3Δ  strains. Known phenotypes 
of yeast erg3 null mutants (hypersensitivity to cycloheximide and inability to grow on 
acetate) were complemented by plasmids expressing either S. cerevisiae ERG3 or C. 
reinhardtii ERG3 cDNA. A) S. cerevisiae ADH1 promoter plasmid used to express ERG3 
genes. Haploid yeast carrying the erg3Δ::URA3 allele were transformed with the 
designated plasmids and plated on dextrose minimal media lacking leucine (YMD minus 
Leu) to select for transformants. Single colony isolates were then re-streaked on minimal 
media lacking leucine and containing cycloheximide (0.13 µg/mL) (B) minimal media 
lacking leucine and containing acetate as sole carbon and energy sources (C), and on 
YMD lacking as overall growth control (D). Yeast mutant for ERG3 and containing the 
vector plasmid lacking an insert cannot grow on cycloheximide or acetate, while cells 
containing the plasmid expressing either yeast or Chlamydomonas ERG3 are able to 
grow. Each pair of plates represents erg3Δ yeast sporulated from two independently 
isolated diploid knockout isolates, 1+2 are DDY4259 and DDY4260 transformed with 
the vector only, 3+4 are DDY4261 and DDY4262, the same strains transformed with 
ADH1-yeast ERG3, and 5+6 are DDY4263 and DDY4264 with ADH1-Chlamydomonas 
ERG3. For the second panel, 7+8 are DDY4253 and DDY4254 transformed with the 
vector only, 9+10 are DDY4255 and DDY4256 transformed with ADH1-yeast ERG3, 
and 11+12 are DDY4257 and DDY4258 with ADH1-Chlamydomonas ERG3. 
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Table 4.2.  Plasmids used in this study. 
 










membranes compared to the complemented strains with the ERG3 ORF from C. 
reinhardtii and S. cerevisiae (Figure 4.6).  Gas chromatography data contained peaks 
with retention times for the ergosterol standard, DDY 4263, and DDY 4261 respectively 
at 11.46, 11.46, and 11.47 minutes.The mass ions coinciding with these specific retention 
times gives spectral data with ions 468, 363, 337, and 253 m/z, previously described as 
ergosterol mass ions by Griffiths et al. (Griffiths et al., 2003).  These experiments 
demonstrate that ERG3 from C. reinhardtii can restore ergosterol biosynthesis in yeast. 
4.3  Discussion                                                                                                       
 Ergosterol is the major sterol found in membranes of C. reinhardtii.  However, 
sterol biosynthesis is not well understood in this organism.  Several sterol mutant strains 
previously were identified in C. reinhardtii by selecting for resistance to the polyene 
antibiotic, nystatin (Bard et al., 1978, Salimova et al., 1999). Polyene antibiotics function 
by forming complexes with the sterols in the membrane and decreasing the membrane 
selective permeability, and thereby causing cell death (Lampen, 1966). In the past, this 
method of selection was used to identify ergosterol mutants. However, very little is still 
known about the substrate-enzyme specificity of the ergosterol biosynthetic pathway 
enzymes in C. reinhardtii.  Unlike C. reinhardtii, several ergosterol mutants have been 
identified in yeast, and their phenotypes have been well documented (Osumi et al., 1978).  
Yeast genetics allows not only the study of the function of yeast genes, but is also useful 
for cross-species complementation studies.                                                                   
 ERG3 encodes a sterol C-5 desaturase, and belongs to the fatty acid hydroxylase 
superfamily.  This superfamily of proteins includes C-5 sterol desaturases as well as C-4 
sterol methyl oxidases (Marchler-Bauer et al., 2007, Marchler-Bauer et al., 2005, 
Marchler-Bauer & Bryant, 2004).  This family of proteins possesses four putative iron-
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binding domains (Miyazaki et al., 1999).  Loss of ERG3 function leads to an apparent 
loss of ergosterol in the membrane and an increase in the closely related precursor, 
episterol.  The replacement of ergosterol with episterol in yeast leads to increased 
sensitivity to cycloheximide and an inability to grow with acetate as a sole carbon source 
(Smith & Parks, 1993). The efficient gene replacement techniques used in Sacchromyces 
cerevisiae, has allowed for the creation of mutant strains in which the ERG3 gene has 
been replaced with URA3 (Rothstein, 1983, Wach et al., 1994). In the work described 
here we were able to complement S. cerevisiae ERG3 haploid knockouts with both yeast 
and the C. reinhardtii ERG3 ORFs. When these genes are put back into erg3Δ yeast 
strains, the resultant transformants show an increase of ergosterol in the membranes, 
increased resistance to cycloheximide and a restored ability to grow on the non-
fermentable carbon source acetate.                                                                                
 While the Chlamydomonas ERG3 ORF does complement the mutation, it must be 
noted that it does not complement as completely as the yeast ERG3 gene.  There are 
several explanations for this.  Traditionally, 2 micron plasmids have been used in yeast 
for heterologous complementation, in order to increase the copy number of the plasmid 
and circumvent any issues regarding variations in protein stability, codon usage, and 
enzyme activity across species (Ludwig et al., 1993). This study uses a moderate copy 
number plasmid.  Secondly, yeast and Chlamydomonas undergo two very different 
biochemical pathways for the production of sterols.  Yeast use the traditional MVA (IPP) 
pathway for the synthesis of sterols, while Chlamydomonas utilizes the DOXP pathway 
for the synthesis of sterols (Lichtenthaler, 1999).  Evolutionary differences across species 
allow for several variations in the ergosterol biosynthetic pathway.  For example, 
Chlamydomonas and S. cerevisiae produce precursors to ergosterol by two independent 
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Figure 4.6. GC/MS data.  Total ion chromatographs were analyzed to look specifically 
for the 100% ion of ergosterol.  Mass ion 363 gives the best indication of the presence or 
absence of ergosterol in the samples. (A) Ergosterol standard, (B) Lipid extract from 
DDY4259 vector control, (C) DDY4263 expressing C.reinhardtii ERG3, (D) DDY4261 
expressing S. cerevisiae ERG3.    
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pathways so therefore similar enzymes can often catalyze different reactions (Gachotte et 
al., 1996, Lichtenthaler, 1999).  Finally, ergosterol biosynthesis is a very metabolically 
taxing process that requires molecular oxygen, sources of energy, and optimal 
temperatures (Parks & Casey, 1995).  Despite these potential complications, 
complementing the yeast ERG3 null mutation with the ERG3 gene from Chlamydomonas 
reinhardtii allows for the production of ergosterol, and increased survival of the cells 
during exposure to cycloheximide and growth on acetate.                                      
 Elucidation of the ergosterol biosynthetic pathway in Chlamydomonas reinhardtii 
is of great importance. There continues to be an interest in plant and algal sterols for 
commercial use as dietary supplements, and as components of cosmetics and 
pharmaceuticals (Fernandes & Cabral, 2007). For example, experimental evidence has 
shown that uptake of plant sterols can help to reduce cholesterol levels in humans 
(Moghadasian & Frohlich, 1999, Tapiero et al., 2003).  The similarity of the C. 
reinhardtii ERG3 gene with that of higher plants indicates that the Chlamydomonas 
system may provide an excellent model system in which to study plant sterol 
biosynthesis.  Better understanding of this pathway will lead to the development of 
directed knockout mutant strains in Chlamydomonas that may allow for overproduction 
of specific ergosterol precursors. Unlike crop plants, C. reinhardtii is relatively 
inexpensive to grow and with the new innovations in photobioreactors, large cultivation 
of algal lipids may begin to become more efficient. Although, this is the first work to 
elucidate the molecular function of any ergosterol biosynthetic enzyme in C. reinhardtii, 
further studies will hopefully uncover greater significance of this pathway in the 




5.1  Chlamydomonas reinhardtii Ergosterol Biosynthetic Genes                                   
 While research in the field of ergosterol biosynthesis in C. reinhardtii has been 
dormant for over a decade, the genes involved in the pathway have now been fully 
elucidated.  Investigations of these genes have led to the discovery of two key genes, 
CPI1 and CAS1(Chapter 3), that show similarities to the higher plant biosynthesis of 
sterols.  Bioinformatics data presented here support the idea that C. reinhardtii produces 
cycloartenol as a precursor to ergosterol instead of lanosterol as seen in fungal species 
like S. cerevisiae.  EST data have provided the support to identify whether or not these 
genes are expressed.  In addition, many of these genes are expressed at reasonable levels 
as evidenced by the Q-RT PCR data presented in Figures 3.17, 3.18, and 3.19.  Even 
though the presence of some of the genes, for example ERG9, is not strongly supported 
by EST data, there is no evidence to dismiss their involvement in ergosterol biosynthesis.  
Most of the sequences for these genes now have Accession numbers in the NCBI Pubmed 
Database (Table 5.1). While the development of a model pathway for ergosterol 
biosynthesis in C. reinhardtii was one of the major goals of this dissertation (Figure 3.2), 
there is still a vast amount of work left to be done in order to begin to fully characterize 
these genes and the enzymes for which they encode.  Bioinformatics data gives valuable 
information about the locations and putative functions of the proteins, but sufficient 
experimental evidence is needed to confirm and characterize the function of each protein.
 While sterol fluctuations have been implicated in the cell cycle (Janero et al., 
1982), there has not been a correlation shown between reflagellation and ergosterol 
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biosynthesis until now.  Innovations in molecular biology techniques have allowed the 
perfection of quality Q-RT PCR analysis of genes in C. reinhardtii.   Several key genes 
(ERG3, ERG4, ERG5, ERG6, ERG7, ERG11) (Figure 3.18) in the ergosterol 
biosynthetic pathway do show upregulation during reflagellation lending to the 
hypothesis that in order to reflagellate the cell, new membranes must also be synthesized.  
The previously documented ergosterol mutant (Bard et al., 1978), cc652, does show a 
lack of expression of ERG5 (Figure 3.17), which completely supports the original data 
from GC/MS profiles (Bard et al., 1978) regarding the absence of a C22-desaturase.  In 
addition, bald mutants also were analyzed by Q-RT PCR.  This analysis, however, 
provided no conclusive data (Figure 3.19) from the specific sterol genes implicationed in 
the complete lack of flagella.                                                                                                   
5.2  Chlamydomonas reinhardtii ERG3 Complements erg3Δ  Yeast Mutants               
 The design of the working model for ergosterol biosynthesis in C. reinhardtii, 
bioinformatics analysis and Q-RT analysis of the specific genes involved gave a unique 
foundation by which I could then begin to analyze the genes by heterologous 
complementation in yeast.  Sterol biosynthesis is variable among eukaryotic species.  
Higher plants metabolize squalene epoxide to cycloartenol to produce ergosterol as well 
as other sterol molecules, while yeasts metabolize squalene epoxide to lanosterol (Figure 
3.7).  This variation in substrate specificity and product formation can often make 
heterologous complementations with these genes quite difficult.  The strategy for 
approaching this potential problem was to choose several genes in the pathway to study.  
ERG3 and ERG11 were both analyzed.  While ERG11 in yeast catalyzes the substrate 
lanosterol, while in higher plants the ERG11 ortholog CYP51G1 catalyzes the substrate 
obtusifoliol.  Heterologous complementation was unsuccessful due to high substrate 
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specificity of the enzymes.   Since ERG3 catalyzes the conversion of episterol to ergosta- 
5,7,24(28)- trienol (Figure 4.1) in yeast and higher plants, this gene was a likely choice 
for complementation.  Several other genes of the pathway are homologous and did show 
some sequence similarity, but their substrate specificities varied between higher plants 
and yeast; the Erg3p specificity for episterol  allowed the complementation to be a 
success. 
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Table 5.1. Gene names and NCBI Accession Numbers for Genes of the Ergosterol 





FUTURE AND LONG RANGE SIGNIFICANCE OF THIS RESEARCH 
 Sterol biosynthesis has been studied for several decades and has been proven to 
be at the pinnacle of some of the most important discoveries in science and medicine.  
The longevity of this field of science is due in part to its complexity and interlocking 
nature with so many other biochemical pathways.  While basic sciences research has 
provided us with several model systems to analyze sterols, the study of sterol 
biosynthesis in C. reinhardtii is still in its infancy.  The data presented in this dissertation 
will hopefully open the door for future studies of sterol biosynthesis in C. reinhardtii. 
Bioinformatics analysis provides the framework by which a putative pathway could be 
designed for future testing. The use of heterologous complementation in yeast provided 
me with the ability to test the function of ERG3 in C. reinhardtii.  Quantitative RT PCR 
analysis allowed a closer look at the regulation of these genes during reflagellation as 
well as analysis of ergosterol genes in bald, flagella-less mutant strains of C. reinhardtii.  
 In spite of the experiments presented in this dissertation, there are still many 
questions that have yet to be formulated and answered.  Homologous recombination and 
use of knockout technologies are just beginning to be perfected in C. reinhardtii. In years 
to come, it may become increasingly easier to target specific genes of the ergosterol 
pathway and measure its affects and study phenotypic changes.  Sterol biosynthesis 
intersects with so many other biochemical pathways, and it will be interesting in the 
future to manipulate genes of the ergosterol pathway in order to overproduce other 
phytosterols for hormone replacement therapies, natural birth control or even production 
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of natural dietary supplements.  While it has been found that plant sterols in the presence 
of cholesterol precursors can put undue stress on the aortic valve (Helske et al., 2008), 
better understanding of the genes of the pathway in this alga, may allow us to create 
efficient synthetic, ingestible plant enzymes. These enzymes can be used to supplement 
the sterol enzymes in humans that can degrade these arterial plaques due to their substrate 
specificity of the cycloartenol precursors of the sterol pathway versus the more higher 
eukaryotic lanosterol pathway.                                                                                                        
 Another potential manipulation of this pathway could lead to use of this model 
system for biofuels production. While all of these future studies are quite intriguing, 
scientists may argue of the cost effectiveness of mass-producing Chlamydomonas.  With 
the new wave towards producing a greener economy, I predict that in the next ten years, 
scientists will develop functional economical photobioreactors that will be able to 
generate algal biomass for fuel production with equal or lesser cost than our present 
technologies in petroleum deep sea drilling rigs.  These photobioreactors will be located 
primarily in cities of high CO2 emission, next to some of our oil refineries and factories, 
and in densely populated cities.                                                                                     
 While basic sciences research has provided us with several model systems to 
analyze sterols, the study of sterol biosynthesis in C. reinhardtii is still in its infancy.  But 
there is a vast interest in studying algal lipid biosynthesis for biofuels production.  One 
major example is Botryococcus braunii.  This green photosynthetic algae is known for 
making a vast array of hydrocarbons and methylated squalenes.  Like C. reinhardtii, it 
too primarily synthesizes its lipids by the DOXP pathway.  Understanding the  genes 
involved in lipid biosynthesis may help to begin to identify specific precursors that can be 
used as biofuels or  other commercial products.  Basic science research has been the 
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foundation for some of the greatest innovations of our time.  Specifically, sterol 
biosynthesis has been implicated in several aspects of human disease from Alzheimer’s 
disease to polycystic kidney disease.  Because we now know the sterol components of the 
flagella, there may be some future interest in monitoring the movement or production of 
sterols in the whole cell to the flagella.  GFP tagging is becoming a widespread technique 
in C. reinhardtii.  Tagging ergosterol biosynthetic genes to look at activity during 
reflagellation may be a future experiment that may give greater detail as to whether or not 
these genes play a role in the regrowth of the flagella.  Recent flagella research focused 
primarily on IFT proteins, but it is interesting to note that there are equal concentrations 
of sterol in the whole cell and flagella according to Gealt et al. (Gealt et al., 1981).  If we 
presume that the ER is producing sterols that are transported from the whole cell 
extending out to the flagella, one might agree that the sterols must be resynthesized 
everytime flagella regenerate.  This hypothesis supports the idea that ergosterol 
biosynthetic genes have to turn on in order for membrane biogenesis of the flagella to 
occur. If the flagellum has a very similar proportion of sterols compared to the whole 
cell, then it would make sense that other lipid classes would be found in the flagellar 
membranes, but according to the literature (Gealt et al., 1981) this is not the case. With 
the knowledge that flagella is comprised primarily of sterol and fatty acid according to 
Gealt et al. (Gealt et al., 1981), there must be some unique cellular process that allows 
the flagellar membrane to exclude other lipid classes except sterols and fatty acids, and if 
this is the case, I have provided evidence that ergosterol biosynthesis plays some role in 
membrane biogenesis during reflagellation.                                                                         
 It is my hope that with new experimental technologies in C. reinhardtii, it will 
become easier to study these questions of interest.  The primary challenge for researchers 
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in this field is the technology available to study these questions in this model system, but 
it is my firm belief that as newer protocols are developed and successfully tested, 
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